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The tryptophan-rich basic protein (WRB) has recently been proposed to act as
the receptor of tail-anchored (TA) proteins. Together with the cytosolic protein
TRC40 it presumably builds the main components of the posttranslational mem-
brane insertion pathway in mammalian cells. A mutation in the wrb homologue
gene in zebrafish causes visual, hearing, and balance deficits, as observed in the
pinball-wizard (pwi) zebrafish mutants. In this study, I investigated the role of
WRB in hearing by studying the synaptic transmission at the first auditory synapse,
the cochlear inner hair cell (IHC) ribbon synapse in the Pwi conditional knockout
mice. In this mouse model, the Wrb gene was targeted for excision through Cre-
mediated homologous recombination in tissues that express the vesicular glutamate
transporter-3. The findings indicated a progressive hearing loss accompanied by
epileptic attacks and vestibular deficits. Further, the knockout animals did not
survive beyond two months after birth. Patch-clamp recordings revealed a normal
exocytosis of the readily-releasable pool of vesicles in IHCs, but diminished sus-
tained component of exocytosis, suggesting a defect in vesicle replenishment. These
findings were further supported by ultrastuctural analysis of the knockout IHC rib-
bon synapses, where unusually large vesicle clusters were observed together with
significantly fewer ribbon-associated vesicles. Otoferlin, a putative calcium sensor
for synaptic vesicle fusion and/or priming factor at the IHC ribbon synapse, has
recently been predicted to be a TA protein. In support of the hypothesis that the
disrupted pathway of membrane insertion could affect the molecular components of
the IHC synapse, otoferlin protein levels in IHCs of the Pwi knockout mice were
decreased. Moreover, the expression of TRC40 was also strongly reduced. In conclu-
sion, the IHC synaptic dysfunction probably contributes to the progressive hearing
loss in the Pwi knockout mice. Although not yet quite understood, this synaptic
defect might be attributed to deficits in certain IHC synaptic proteins, like otofelin
that are disrupted upon deletion of the WRB protein.
Furthermore, as a parallel study, a viral silencing approach was established, utilizing
adeno-associated viruses for the delivery of miRNA-like silencing molecules in the
developing otocyst. The results of the effort to knock-down the protein levels of
xv
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Animals have evolved over millions of years in continuously changing environments,
expanding and dominating a variety of new milieus. Their chances of survival and
successful settlement in a habitat are defined by the senses that they have developed.
The sense of hearing appeared quite early, originating in the Triassic period (250–220
million years ago), when the first primitive hearing organ, a short auditory papilla
of few hundred hair cells, was established and developed thereafter simultaneously
in the three major amniote vertebrate lineages, i.e., mammals, birds, and reptiles
(Manley, 2000). In invertebrates, hearing, is mostly related to gravity and vibration
changes, captured by ciliated primary sensory cells located in different regions of the
body. Hearing and the auditory system, respectively, enabled animals to capture
sound and to distinguish differences in its temporal characteristics, amplitude, and
spatial profile and thus, to respond effectively to the demands of their environment.
For humans is an invaluable gift, enriching our social interaction and enhancing our
comprehension of the world.
1.1 Mammalian Ear
1.1.1 Basic Anatomy
The work of great scientists, such as the physiologist Hermann von Helmholtz (1821–
1894) and the anatomist Marquis Alfonso Corti (1822–1876), on preservation tech-
niques for the mammalian auditory system, contributed grandly to the anatomical
characterization of the auditory system and the understanding of the physical prop-
erties of sound transduction, from a traveling wave along the cochlea to an electrical
response by the sensory cells.
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1. Introduction
The hearing organ in mammals is divided into three anatomical parts: the ex-
ternal ear with the ear canal, the middle ear with the ear drum and ossicle chain,
and the inner ear with the cochlea and vestibular organs. The middle and inner
ear are housed inside the temporal bone. The inner ear is well protected inside the
bony labyrinth. The cochlea (from the Greek word κoχλιας, meaning snail) consists
of a system of fluid-filled cavities that are separated from each other by Reissner’s
membrane and the basilar membrane. Two of these cavities, i.e., the scala vestibuli
and scala tympani (Figure 1.1 b) are filled with perilymph (a high-sodium solution
similar to the extracellular solution elsewhere in the body) and are linked at the apex
of the cochlea at the helicotrema. Between them is the scala media, which houses
the auditory sensory epithelium, i.e., the organ of Corti. The organ of Corti primar-
ily consists of sensory cells and supporting cells and lies on the basilar membrane
(Figure 1.1 c). The apical side of the sensory epithelium is bathed in endolymph
(high-potassium solution). The lateral wall of scala media is made up of the stria
vascularis, which is rich in blood vessels and establishes the ionic composition and
electrical potential of the endolymph.
1.1.2 Organ of Corti
The organ of Corti is an epithelium of ∼11 mm length in mice and ∼34 mm in
humans (Ashmore, 2008). Two types of sensory receptor cells are positioned in 4
distinct rows throughout the entire length of the organ of Corti, i.e., one row of inner
hair cells (IHCs) and 3 rows of outer hair cells (OHCs). Different types of supporting
cells and nerve fibers surround these cells. The sensory hair cells have two distinct
surfaces, i.e., apical and basolateral, which differ in structure and function. The
apical side receives the auditory stimulus, while the basolateral surface transmits
the signal through the synapses that are formed there. On their apical surface,
these cells display microvilli, composed of parallel actin filaments, the “stereocilia”,
which form the hair bundle. Stereocilia are actively motile structures, connected
with each other via tip links and lateral links, which hold the bundle together.
The bundle is subjected to a fine-coordinated movement every time an appropriate
auditory signal arrives in the cochlea. The bundles of the OHCs are attached to the
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Figure 1.1: Anatomy of the cochlea. (a) Anatomical drawing of a cross-section of the whole
cochlea depicting the eighth cranial nerve as it exits the cochlea and the cochlear ducts, (b) one
cross-section of the cochlea, indicating the fluid-filled cavities, scala vestibuli, scala media, and
scala tympani and the position of the organ of Corti, (c) the organ of Corti with the two types of
sensory cells (IHCs and OHCs) and the supporting cells. (Figure adapted from Pearson Education
Inc., 2006)
tectorial membrane and are exposed to movements whereas the bundles of the
IHCs are bathed inside the endolymph and hence, are subjected to deflections caused
by the fluid movements.
1.1.3 Innervation of the Cochlea
The central axis of the cochlea is the bony modiolus, which shapes a passageway for
the afferent (toward the brain) and efferent (toward the periphery) auditory nerve
fibers (ANFs). It houses the somata of the bipolar spiral ganglion neurons (SGN)
that give rise to afferent ANFs and send peripheral neurites contacting the IHCs
and OHCs, respectively. In mice, each IHC forms synapses with ∼20 unbranched
3
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neurites of type I SGN (Meyer and Moser, 2010). ANFs of type I SGN are thick
and myelinated fibers. In cats, it has been demonstrated that the afferent nerve
fibers innervating the pillar side of IHCs have a large diameter, low threshold, and
high spontaneous firing rate, while those from the modiolar side have a small diame-
ter, high threshold, and low spontaneous firing rate (Merchan-Perez and Liberman,
1996). Additionally, lateral olivocochlear neurons (efferents) project to the afferent
fibers beneath IHCs. However, early in development, in mice, the efferents termi-
nate directly on the IHCs (Sobkowicz and Slapnick, 1994). Conversely, the afferent
innervation of the OHCs consists of a small number of thin, unmyelinated fibers
originating from type II SGNs. One such afferent may contact 6–100 OHCs, most
often within the same row (Peter Dallos et al., 1996). Most of the innervation of the
OHCs comes from large-diameter efferent myelinated fibers, i.e., the medial olivo-
cochlear neurons. All the afferent ANFs exit the cochlea and project centrally to the
brainstem via the eighth cranial nerve, up to the auditory cortex. Every individual
ANF responds to a slightly different characteristic frequency that is determined by
the position of the fiber termination in the organ of Corti (Dallos, 1992; Liberman,
1982). This implies that every hair cell is capable of recognizing and responding to
a specific range of sound frequencies as a consequence of active and passive cochlear
micromechanics. This tonotopic organization of the entire cochlea, whereby high
frequency and low frequency sound cause vibrations in the base and the apex of the
cochlea, respectively, is followed by tonotopicity throughout the afferent auditory
pathway up to the auditory cortex.
1.1.4 From Sound Waves to Electrical Responses
Sound waves are collected by the external ear and travel through the ear canal
reaching the tympanic membrane. There, they induce mechanical vibrations of
the tympanum and subsequently set the ossicular chain (malleus, incus, stapes),
which is connected to the tympanic membrane, into motion. The movement of the
stapes causes a traveling wave of the basilar membrane. As a consequence, the
organ of Corti is leading to mechanoelectrical transduction by inner and outer hair
cells. Deflection of the hair bundles of inner and outer hair cells is a well organized
4
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process, which modulates tension on the tip links, directing the open probability of
cation-selective mechanoelectrical transduction (MET) channels.
Figure 1.2: The journey of a sound wave in the cochlea. Illustration which shows the middle
and inner ear with uncoiled cochlea for simplicity. The sound waves reach the tympanic membrane
and set the ossicular chain (malleus, incus, and stapes) into motion. The forces of this motion
create pressure in the entire cochlear ducts by setting perilymph in circulation. The distance that
a traveling wave spans inside the cochlea, depends on its frequency. (Figure adapted from John
Wiley and Sons, Inc.)
Displacement of the hair bundle toward the longest stereocilium (positive dis-
placement) increases the open probability of MET channels and results in the influx
of mostly K+ ions. The ensuing receptor potential drives prestin-mediated electro-
motility in OHCs (Dallos, 2008; Zheng et al., 2000) and mediates the influx of Ca2+
from voltage-sensitive calcium channels and facilitates the release of neurotransmit-
ter from the afferent synapses in IHCs and OHCs.
5
1. Introduction
1.2 The IHC Ribbon Synapse
The auditory sensory system is unique in the nervous system in its accuracy and
speed of the transduction of stimuli, encoding, and representation in the primary
auditory cortex. IHCs are the genuine sensory cells of the auditory system, which
sustain neurotransmission continuously, in response to graded changes of membrane
potential. To accomplish these roles, IHCs form specialized synapses, equipped with
a sophisticated protein machinery.
Chemical synapses enable the communication between two sensory/nerve cells by
synaptic vesicle exocytosis, which is restricted to a small section of the presynaptic
plasma membrane, the active zone (AZ). The active (AZ) of every synapse should
fulfill three principal functions: i) collect a sufficient number of vesicles to be avail-
able for release upon stimulus, ii) recruit voltage-gated calcium channels, where Ca2+
enters and triggers exocytosis, iii) couple the presynaptic site with the postsynaptic
neuron with cell-adhesion molecules. The proteins that localize at the AZ create
a cytomatrix (Zhai and Bellen, 2004) and assist the structural organization of the
synapse, as well as the vesicle release (exocytosis) and retrieval (endocytosis).
IHC synapses differ from synapses of the central nervous system (CNS) in many
aspects. They are equipped with an electron-dense structure called the synaptic
ribbon, which is anchored to the active zone and extends from the presynaptic site
into the cytoplasm. In the mouse IHCs ribbons vary in shape and size (100–400
nm), typically appear to be ≤ 200 nm in width (Moser et al., 2006). Depending
on the position of the IHC along the tonotopic axis of the cochlea, the number of
ribbon synapses varies (Meyer et al., 2009). The functional relationship between a
ribbon-type AZ in the presynaptic IHC and an afferent postsynaptic neuron com-
prises the afferent synapse, which carries the “responsibility” of maintaining an
“inexhaustible” supply of synaptic vesicles (SV).
1.2.1 Exocytic performance at the IHC ribbon synapse
The active zone, with its hallmark the ribbon, serves as a platform for the fusion
of vesicles, carrying the neurotransmitter glutamate upon Ca2+ influx from Cav1.3
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L-type voltage-gated calcium channels (Brandt et al., 2003; Platzer et al., 2000).
Glutamate is loaded into the vesicles by the glutamate transporter VGLUT3, the
exclusive glutamate transporter isoform in IHCs. Lack of VGLUT3 leads to deafness
(Ruel et al., 2008; Seal et al., 2008). When glutamate is released into the synaptic
cleft it binds to postsynaptic α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
(AMPA) receptors and triggers the generation of action potentials in afferent neu-
rons (Glowatzki and Fuchs, 2002; Rutherford et al., 2012).
The main contribution of the ribbon to the synaptic transmission is the accumula-
tion of synaptic vesicles close to the AZ. Indeed, different populations of SVs have
been identified around the ribbon; either associated with it, or in close proximity,
or beneath the ribbon, docked to the presynaptic membrane (Lenzi et al., 1999).
Therefore, multiple roles have been attributed to the ribbon, i.e., it tethers vesicles,
which are thought to be involved in exocytosis (LoGiudice et al., 2008; Snellman
et al., 2011), it may stabilize the multiple release sites within the AZ (Frank et al.,
2010; Khimich et al., 2005), and/or may promote homotypic fusion of synaptic vesi-
cles before exocytosis (Parsons and Sterling, 2003).
In mouse IHCs, ribbon tethers ∼100–200 vesicles (Khimich et al., 2005). Upon stim-
ulus application, the mature IHCs respond in two subsequent phases, i.e., a phase
of fast and slow vesicle release. The fast phase is attributed to the fusion of vesicles
that are docked, close to the calcium channels. They sense the Ca2+ influx and
undergo exocytosis (readily releasable pool of vesicles [RRP]; RRP size: 7.4 fF, 200
vesicles) (Beutner and Moser, 2001). The slow phase is believed to primarily rep-
resent the replenishment of the vesicles into the RRP (Meyer et al., 2009; Nouvian
et al., 2006) Pangršič et al., 2010) and their subsequent fusion (Moser and Beutner,
2000).
1.2.2 Molecular composition of the IHC ribbon
The main structural component of the ribbon, and also unique to this structure,
is RIBEYE. It consists of the unique aminoterminal, proline-rich-A domain, and a
B domain, identical to the C-terminal domain of the nuclear co-repressor protein 2
(CtBP2). RIBEYE domains mediate homotypic interactions that support the role
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of RIBEYE as a scaffold molecule (Schmitz et al., 2000). CtBP2 and its isoform
CtBP1, localize both at the ribbon (tom Dieck et al., 2005).
Known interaction partner of RIBEYE/CtBP2 is bassoon (tom Dieck et al., 2005),
which together with piccolo consist the cytomatrix scaffold of the ribbon. Bassoon’s
role at ribbon synapses has been suggested to be the anchoring of the ribbon to
the active zone, after the finding that in a bassoon partial-deletion mouse mutant,
ribbons were absent or mislocalized from the AZ (Khimich et al., 2005). Inner hair
cells of these mice have a smaller RRP and reduced sustained exocytosis (Frank
et al., 2010; Khimich et al., 2005), as well as perturbed clustering and organization of
Cav1.3 L-type voltage-gated calcium channels at the AZ (Frank et al., 2010). Thus,
it appears that bassoon together with the ribbon organize the calcium channels at
the presynaptic sites. The role of piccolo in hair cells remains to be clarified.
ERC (ELKS/CAST) and Rab3-interacting proteins (RIMs) have been identified
as further scaffold molecules of the ribbon-type AZ of photoreceptors (tom Dieck
et al., 2005; Ohara-Imaizumi et al., 2005), whose presence at the IHC synapse still
need to be verified (Gebhart et al., 2010). Interactions with the channels are also
promoted by RIMs and RIM-binding proteins, with the first binding through their
PDZ domains to the α subunits of L-type calcium channels (Coppola et al., 2001). In
CNS synapses RIMs participate at vesicle docking and priming (Deng et al., 2011).
1.2.3 Molecules involved in the IHC neurotransmission
The fusion of synaptic vesicles with the presynaptic membrane is accomplished by
interactions of plasma membrane-associated and vesicle-associated proteins. Being
first reported in CNS synapses, the N-ethylmaleimide-sensitive factor attachment
protein receptors (SNAREs), which include the vesicular proteins synaptobrevin 1
and 2 and the presynaptic membrane proteins syntaxin 1 and SNAP-25, consist
the minimal protein machinery for fusion between two membranes. Complexins,
synapsins, and synaptophysins participate also in this process. Finally, calcium,
which is the triggering signal for fusion to happen, binds to the calcium sensor
synaptotagmin and this initiates the protein-protein interactions that will lead the
SVs to fusion.
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The scenery at the IHC synapse is different. As opposed to CNS, synaptophysins,
synapsins (Safieddine and Wenthold, 1999), and complexins (Strenzke et al., 2009)
have not been detected and no exocytosis defect was even observed in a complexin
knockout (KO) mouse (Strenzke et al., 2009). Controversial evidence exists about
the expression of neuronal SNAREs in IHCs. Whereas their expression was wit-
nessed by many individual efforts (Safieddine and Wenthold, 1999; Uthaiah and
Hudspeth, 2010), some more recent evidence argued against the presence of neu-
ronal SNARE proteins in IHCs (Nouvian et al., 2011). Additional efforts to cleave
SNAREs by clostridial neurotoxins did not block exocytosis (Nouvian et al., 2011).
Still, their expression is further debated and the question of how IHCs mediate
synaptic vesicle fusion remains open.
Furthermore, the expression and function of the vesicle proteins synaptotagmins at
IHCs have not yet been fully clarified. Synaptotagmins are a big family (15 isoforms)
of C2 domain proteins, many of which bind Ca
2+ and phospholipids. Synaptotag-
mins 1 and 2 are considered to serve as the main calcium senors of SV fusion in
CNS synapses and interact with SNAREs. Nevertheless, at mature IHCs synapses,
neither synaptotagmin 1 nor synaptotagmin 2 are expressed (Beurg et al., 2010;
Reisinger et al., 2011). Alternatives for the calcium sensor at IHCs have been pro-
posed to be synaptotagmin 4 and otoferlin. The first one has been detected in IHCs
(Safieddine and Wenthold, 1999) and was suggested to be required for linearizing
the Ca2+ dependence of exocytosis (Johnson et al., 2010). Otoferlin is so far the
most prominent candidate for calcium sensor (Roux et al., 2006) (see later), but
still, the precise nature of its function is not yet deciphered. To conclude so far,
IHC ribbon synapses seem to operate with an unconventional exocytic machinery
differing from that of CNS synapses.
1.3 Otoferlin, a multi-C2 domain protein
Otoferlin is a member of the ferlin family, an ancient protein family existing through-
out the eukaryotic kingdoms (Lek et al., 2012). The main characteristic domains
of ferlins are the FerB domain of unknown function and the multiple cytosolic C2
domains. Ferlins contain between 5–7, with otoferlin probably containing 6 (C2A-
9
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F). Synaptotagmins, known as regulators of calcium-mediated membrane fusion,
have two such domains, both binding calcium and phospholipids. X-ray analysis of
the crystal structure of the otoferlin C2A domain revealed an eight β-strand struc-
ture, typical for C2 domains, which was folded with type II topology (Helfmann
et al., 2011). In contrast to C2A domain, the other C2 domains of otoferlin can
bind calcium and phospholipids (Johnson and Chapman, 2010), although this is
controversial for C2F (Pangršič et al., 2010). Otoferlin displays a single C-terminal
transmembrane domain (TMD). The existence of the TMD close enough to the
C-terminus necessitates posttranslational insertion into the target membrane, as is
typical for tail-anchored proteins (TA) (Lek et al., 2012).
Otoferlin protein shares 28% homology with the Caenorhabditis elegans FER-1 pro-
tein (Achanzar and Ward, 1997) and 38% homology with the human dysferlin (Ya-
sunaga et al., 1999). Reports from various pathologies caused by mutations in
ferlin proteins, have indicated that the members of this family participate in cel-
lular trafficking (Bernatchez et al., 2009; Doherty et al., 2005), membrane repair
(Covian-Nares et al., 2010), and possibly calcium-triggered processes (Bansal et al.,
2003; Dulon et al., 2009). Characteristic examples of pathologies caused by ferlin
proteins are the muscular dystrophy, caused by an autosomal recessive inherited mu-
tation in dysferlin and non-syndromic deafness, attributed to a mutation in otoferlin
(Yasunaga et al., 1999).
1.3.1 Implication of otoferlin in deafness
The identification of a point mutation inside exon 18 of human otoferlin gene
(OTOF ) was the first time ever that otoferlin protein was linked with hearing.
The mutation, which produced a truncated protein form, was inherited in an au-
tosomal recessive way and caused prelingual, non-syndromic hearing loss (DFNB9)
(Yasunaga et al., 1999). To date, more than 60 pathogenic mutations have been iden-
tified in the OTOF gene (Rodrguez-Ballesteros et al., 2008) (Figure 1.3), which in-
clude nonsense and missense mutations that often affect the C2 domains. Pathogenic
otoferlin mutations cause auditory synaptopathies, where hearing is impaired, but
the otoacoustic emissions are mostly intact, suggesting that otoferlin is not impli-
10
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Figure 1.3: Protein domain structure of otoferlin. Illustration showing the structure of
otoferlin, with 6 C2 domains and one C-terminal transmembrane domain. Known pathogenic
mutations of otoferlin are presented above the structure, and sequence variants on the bottom.
(Figure adapted from Pangršič et al., 2010).
1.3.2 Expression pattern of mouse otoferlin
The expression profile of otoferlin in mouse cochlea changes during development.
By means of immunostaining, it has been shown (Roux et al., 2006) that expression
appears first at embryonic day 16 (E16) in IHCs and at E18 in OHCs. Gradually
becomes more abundant in both cell types, reaching a maximum of fluorescent sig-
nal at P6. While in IHCs otoferlin persists during development and mature life,
in OHCs, vanishes after P6. In the brain, it was detected in cerebellum and hip-
pocampus (Roux et al., 2006). An additional study, proved the same expression in
cochlear IHCs, suggesting a further detection until P9 at the basal part of OHCs
(Schug et al., 2006). Furthermore, with in situ hybridization and RT-PCR, the same
study showed the expression of otoferlin in different areas of the brain (brainstem,
cerebellum, cortex, inferior colliculus, superior colliculus, hippocampus). The distri-
bution pattern of otoferlin in IHCs appears throughout the cytoplasm (Roux et al.,
2006; Schug et al., 2006). Complementary evidence from immunostaining of IHCs
indicates a substantial amount of otoferlin in the presynaptic membrane distribution
(Pangršič et al., 2010).
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1.3.3 Interaction partners of otoferlin
Otoferlin was shown to interact with the heterodimer syntaxin 1/SNAP-25 (Johnson
and Chapman, 2010; Ramakrishnan et al., 2009; Roux et al., 2006) and also individ-
ual C2 domains or combinations of them could support SNARE-mediated liposome
fusion in a Ca2+ dependent manner (Johnson and Chapman, 2010). However, as
mentioned earlier, the expression of neuronal SNAREs at the IHC synapse is ques-
tionable (Nouvian et al., 2011) and therefore these interactions may not be relevant
in vivo.
Other suggested interactions of otoferlin are with the Rab8b GTPase, at the apical
region of the IHCs (Heidrych et al., 2008), with Myosin VI (Heidrych et al., 2009)
and with Ergic2 (Zak et al., 2012). Rab8b has been shown to be involved in sorting
and/or storage of neural recycling endosomes (Gerges et al., 2004), which suggests
participation of otoferlin in endocytosis and the transport of vesicles to the active
zone. However, this hypothesis requires more experimental evidence.
1.3.4 Evidence and hypotheses on otoferlin’s function
Comparison of otoferlin with synaptotagmin has guided the research on the exact
role for otoferlin. Insight into the role of otoferlin came initially from the study of
an otoferlin KO mouse model (Roux et al., 2006). Deletion of the protein caused
profound deafness and abolition of Ca2+-triggered exocytosis (P6 and P15), while
the number of ribbon-associated and docked synaptic vesicles remained normal (at
P15). In addition, the number of synapses in IHCs was reduced by ∼50% in P15
animals. These data were the first evidence for implicating otoferlin into a late step
of exocytosis (e.g., priming or fusion) (Roux et al., 2006). Another mouse model,
which enhanced the understanding of the role of otoferlin, was generated with a
missense mutation (Asp-to-Gly) inside the C2F domain (Schwander et al., 2007).
This mutation, called pachanga, caused a reduction by 70% to otoferlin protein
levels in IHCs and deafness, as indicated by the lack of auditory brainstem responses
(ABR). In response to depolarization, IHCs of this mutant displayed normal RRP
exocytosis, but impaired sustained response, indicative of inability to mantain
efficient vesicle replenishment (Pangršič et al., 2010). The authors specifically
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suggested that otoferlin might be involved in priming as the synapse ultrastructure
seemed unaltered. Moreover, this point mutation caused a slight change in the
secondary structure of otoferlin, as indicated by circular dichroism spectroscopy.
Thus, it was proposed that the reduced protein levels and/or the structural change
on otoferlin may impair its function and the interactions established with other
proteins (Pangršič et al., 2010).
Support of the hypothesis that otoferlin is the calcium sensor at IHC ribbon
synapses, is enhanced by the absence of synaptotagmins 1 and 2 from these
synapses (Beurg et al., 2010; Reisinger et al., 2011). The phenotype of the otoferlin
KO mouse could however not be rescued by overexpressing synaptotagmin 1 in
IHCs, which might happen due to a lack of appropriate interaction partners of
synaptotagmins at the IHC synapse (Reisinger et al., 2011).
Gathering the facts about otoferlin, we could conclude that it is a membrane
protein, localized throughout the IHC cytoplasm and the presynaptic membrane,
with the ability to bind calcium and phospholipids. It is most probably implicated
into a late step of exocytosis, promoting priming of the synaptic vesicles (Pangršič
et al., 2010), and maybe enabling vesicle replenishment. Beyond the role as calcium
sensor, it is speculated that otoferlin participates in the intracellular trafficking of
vesicles from the Golgi network to endosomes and later to the basolateral membrane
of IHCs (Schug et al., 2006; Yasunaga et al., 1999). If this is true, then the subcellular
distribution can be better explained. It would suggest that before otoferlin reaches
the synaptic site, it should get loaded into the vesicle membrane. How and where this
process happens and which other proteins assist otoferlin is not yet known. Being a
tail-anchored (TA) protein, predicted by a bioinformatics screen (Kalbfleisch et al.,
2007), otoferlin must follow a specific pathway until it acquires the final topology
on the membrane.
1.4 Tail-anchored Proteins
The plethora of integral membrane proteins utilize diverse mechanisms for insertion
into phospholipid bilayers. Most of these proteins need to be translocated to the
13
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rough endoplasmic reticulum (ER) to acquire their proper folding and posttransla-
tional modifications before they are sorted to their ultimate cellular compartments.
This translocation can happen either during translation of the nascent polypeptide
chain or after termination of translation, depending on the position of the membrane-
targeting signal.
A particular class of integral membrane proteins, the tail-anchored proteins (TA
proteins), can only be processed posttranslationally by being targeted to either the
ER membrane or the mitochondrial outer membrane (MOM) via a single hydropho-
bic membrane-anchor sequence, which is located very close to the C-terminus of the
polypeptide chain (Kutay et al., 1993). The length of the hydrophobic sequence, as
well as the number of positively charged amino acids that flank it, determine where
(ER or MOM) the TA protein will be inserted (Wattenberg and Lithgow, 2001).
With the exception of TA proteins destined for the MOM, which are targeted there
directly from the cytoplasm (Borgese et al., 2001), all the rest must get inserted first
into the ER and then transferred to their final destination by vesicular transport
(Jantti et al., 1994; Kutay et al., 1995; Linstedt et al., 1995; Pedrazzini et al., 1996).
A variety of enzymatic and regulatory roles in cellular metabolism (cytochrome b5),
apoptosis (Bcl-2), protein localization (Sec6), and membrane trafficking (SNARE
complex proteins) are attributed to TA proteins. By studying the function of each
individual TA protein, multiple insertion pathways have been discovered.
1.4.1 ER-targeting insertional pathways
Insertion to the ER membrane can happen in a cotranslational or posttransla-
tional mode. Chaperone-mediated pathways are used for cotranslational integra-
tion and can be mediated either by signal recognition particle (SRP) and Sec61
protein translocation complex, with GTP hydrolysis, (Abell et al., 2004) or by
ATP-dependent Hsc70/Hsp40 chaperones (Abell et al., 2007). The SRP-dependent
pathway is mainly utilized by integral membrane proteins that have an N-terminal
membrane-targeting signal. SRP is a soluble ribonucleoprotein complex that recog-
nizes the targeting signal of the nascent polypeptide chain, while it is still found in
complex with the ribosome. It shields the polypeptide and targets to the ER mem-
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brane by insertion first into the Sec61 translocation channel (Rabu et al., 2009). An
exception to the SRP pathway mode was discovered for two TA proteins, synapto-
brevin 2 (also known as vesicle-associated membrane protein 2) and Sec61β, where
the pathway is mediated in a posttranslational step. The key feature of SRP recogni-
tion in these cases was shown to be a stretch of hydrophobic residues in the targeting
signals of the proteins (Abell et al., 2004).
Much less understood is the Hsc70/Hsp40-mediated pathway. Two lines of evidence
indicate that these two chaperones can mediate the biogenesis of TA proteins in vitro
(Abell et al., 2007; Rabu et al., 2008), but the exact in vivo pathway is unknown.
A broadly utilized posttranslational pathway is driven by the cytosolic ATPase arsA
arsenite transporter, ATP-binding, homolog 1 (bacterial) (TRC40; previously de-
scribed as ASNA1). The pathway requires the interaction of the transmembrane
domain (TMD) of a TA protein with a soluble cytosolic protein and the formation
of a TMD recognition complex (TRC). This cytosolic factor was found to be TRC40
(Stefanovic and Hegde, 2007). The TRC pathway is a highly ATP-dependent pro-
cess, which drives consecutive cycles of binding and release of TRC40 from membrane
targets competent for TA protein insertion. They proposed the hypothesis that lo-
calization of TRC40 on membranes is a transient, ATP-dependent process, which
aims to deliver the TA proteins to a receptor. The free cytosolic concentration of
TRC40 was detected to be higher relative to SRP, but TRC40 was not found to in-
teract with ribosomes. These facts led the authors to suggest that although TRC40
is more abundant in the cytosol, it can not interfere with nascent polypeptides which
are still in association with the ribosome. Cotranslational arrest of TMD targets
should happen only by SRP-mediated pathway, whereas posttranslational should be
directed by TRC40 (Figure 1.4). Therefore, it was concluded, that these two path-
ways are distinct and never compete for the same targets (Stefanovic and Hegde,
2007). It is also possible that proteins that have “lost” the chance to get arrested
by the SRP pathway use the TRC pathway as an alternative.
Further studies aiming to understand the posttranslational mechanism of mem-
brane protein insertion, led to the identification of another cytosolic heterotrimeric
complex, composed of Bag6/Ubl4A/TRC35 (Mariappan et al., 2010). This complex
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Figure 1.4: The two main membrane insertional pathways. Illustration representing the
cotranslational (upper) and the posttranslational (lower) mode of membrane protein insertion to
the ER membrane. The SRP/Sec61 pathway is utilized mostly by non-TA proteins, starting during
their translation, with the exception of synaptobrevin 2 and Sec61β. Tail-anchored proteins display
membrane-targeting signals very close to the C-terminus that only after termination of translation
exit the ribosome, and then the protein can be recruited to the insertional pathway. The nascent
polypeptide chain is “arrested” by the pre-targeting complex (Bag6/Ubl4A/TRC35) and then
presented to the cytoplasmic factor TRC40, which through an ATP-dependent process delivers the
TA protein to the ER receptor (Get1-Get2). (Figure adapted from (Hegde and Keenan, 2011).)
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acts upstream of TRC40, capturing the TMD of the newly synthesized peptide, as
it exits the ribosome, and then passing the TA protein to TRC40 (Mariappan et al.,
2010).
Lately, the ER specific receptor of TA proteins has been identified to be the
tryptophan-rich basic protein (WRB) (Vilardi et al., 2011). It interacts with the
associated TRC40/TA protein complex via a coiled-coil domain in its structure. As
TRC40/TA complex arrives at the ER membrane, TRC40 delivers the TA protein
to WRB. More light was shed on the TRC pathway, when the receptor partner
of WRB on the ER membrane was discovered (Yamamoto and Sakisaka, 2012).
Identified by mass spectrometry, calcium-signaling modulating cyclophilin ligand
(CAML), is composed of a cytoplasmic domain and three transmembrane domains.
It forms a receptor complex together with WRB on the ER membrane. In cell in
vitro assays, the transmembrane domain of CAML was shown to compete with the
coiled-coil domain of WRB for binding to TRC40, but presence of both proteins
was required for TRC40 binding. Many questions on this pathway remain open.
How exactly CAML and WRB compete for the interaction with TRC40, what is the
order of interaction of TRC40 with the heterodimeric receptor or how exactly the
intermolecule interaction between TRC40 and WRB is mediated, are all questions
which remain to be investigated.
Similar to the mammalian TRC pathway, the GET pathway for TA protein insertion
into the ER is specific to yeast (Saccharomyces cerevisiae). The GET pathway has
been characterized by (Schuldiner et al., 2008) and (Wang et al., 2011). According to
this mechanism, the nascent TA polypeptide binds to the Sgt2/Get4/Get5 cytosolic
complex and, through ATP hydrolysis, is transferred to Get3, the S. cerevisiae
homolog of TRC40. Get4 and Get5 are the yeast homologs of Ubl4A and TRC35,
respectively. Get3 presents the TA protein substrate to the heteromeric Get1/2
receptor on the ER and interacts transiently with it. The coiled-coil domain of Get1
interacts with Get3, similar to the interaction of WRB with TRC40 (Stefer et al.,




1.4.2 Predictions on the profile of the membrane-target sequence
A bioinformatics screen (Kalbfleisch et al., 2007), was the first attempt to iden-
tify similarities between predicted single transmembrane domains of known human
TA proteins and other unknown TA proteins. Although, no common pattern was
identified, the findings confirmed previous biochemical data. The level of hydropho-
bicity and the length of the transmembrane segment of TA proteins targeting the
MOM may be lower and shorter than for TA proteins targeting the ER. Three or
more positively charged amino acids flanking this hydrophobic segment are required
for MOM targeting whereas less are needed for ER targeting (Borgese et al., 2001;
Kuroda et al., 1998). Apparently, TA proteins that do not contain MOM-specific
targeting information are inserted into the ER, which is more prone to accept trans-
membrane segments of different lengths and sequences followed by a C-terminal
polar region of varying sizes and charges. Perhaps the most interesting finding of
this bioinformatics screen was its prediction that human otoferlin is a TA protein;
however, this has not yet been demonstrated biochemically.
1.4.3 Tryptophan-rich Basic Protein - WRB
In an effort to understand the pathogenesis of the congenital heart disease (CHD)
that occurs in more than 40% of patients with Down syndrome, a functional map-
ping study identified the WRB gene inside the CHD gene locus in chromosome
21 (Egeo et al., 1998). The WRB gene produces two transcripts (1.4 kb and 1.6
kb) and encodes a 174 amino acid tryptophan-rich basic protein, WRB (C-terminus
rich in tryptophans and prolines). The evaluation of the WRB tissue expression
was performed by Northern blot analysis on human tissues and WRB transcripts
were detected in the brain, heart, lung, liver, skeletal muscle, pancreas, kidney, and
placenta. Nevertheless, no further study was conducted in order to investigate a
possible implication of WRB in CHD pathology.
Additional knowledge about WRB, resulted from an insertional mutagenesis screen
for visual deficits in zebrafish (Gross et al., 2005). Of all the mutants generated, one
particular was found to carry mutation inside the pwi gene, the zebrafish homolog
of WRB. The pwi mutant displayed extensive acellular regions in the photorecep-
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tor area of the retina (outer plexiform layer–OPL) (Gross et al., 2005). Further
extensive analysis of the pwi zebrafish mutant, showed that this gene also caused
visual, hearing, and balance deficits. When mutated, the Wrb protein affected the
swimming behavior and posture of the fish. As far as the auditory sensory cells
are concerned, the kinocilia of the lateral line neuromast cells were shortened, likely
affecting the mechanotransduction process of the neuromasts, as indicated by the in-
ability of FM dye labeling of the stereocilia of the sensory cells. The mutation further
caused hearing deficits, reflected as lack of acoustic startle response and severely re-
duced microphonic potential. The synaptic activity between the photoreceptors and
the bipolar neurons was reduced, as measured by electroretinography. Pinball im-
munoreactivity appeared generally in the OPL, at the site of photoreceptor-bipolar
cell synapses. In the fish, pwi mutation caused mislocalization of the Rab3C synap-
tic vesicle marker (from the basolateral synaptic region to the apical site), suggesting
a possible role of this protein in synaptic development (Lin et al., unpublished).
The possible implication of WRB in the pathogenesis of CHD has been additionally
supported by a study in medaka fish (Oryzias latipes) (Murata et al., 2009), but
this work was mostly focused on examining the effect of CHD in heart formation
during development.
In conclusion, the most solid evidence for the function of the tryptophan-rich basic
protein can be summarized into two points: WRB is part of the receptor of TA pro-
teins on the ER (Vilardi et al., 2011; Yamamoto and Sakisaka, 2012), and deletion
of wrb gene in zebrafish causes hearing and visual defects (Lin et al., unpublished).
Based on the prediction (Kalbfleisch et al., 2007) that otoferlin, which is likely the
main calcium sensor at the IHC ribbon synapse, is a TA protein, a new hypothe-
sis could be created. Assuming the posttranslational regulation and trafficking of
otoferlin by the tryptophan-rich basic protein, which is the implication of WRB in
hearing?
1.5 RNA Interference - Mechanism and Applications
RNA interference (RNAi) comprises a posttranscriptional mechanism of gene silenc-
ing that is conserved in vertebrates (Caplen et al., 2001; Elbashir et al., 2001) and
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Figure 1.5: miRNA biogenesis pathway. miRNAs are non-coding RNA molecules, transcribed
either from independent miRNA genes or from introns of protein-coding transcripts. The pri-
miRNA molecule (> 100 nucleotides) forms multiple hairpins and bulges, and often contains se-
quences of multiple miRNAs. Two important modification steps take place during the biogenesis
of an miRNA, i.e., the catalysis step by Drosha (an RNase III enzyme) inside the nucleus and the
final processing step by Dicer inside the cytoplasm. At the end of each step, the precursor miRNA
becomes shorter in length until Dicer yields an ∼21-bp double-stranded miRNA molecule with an
unpaired 2-nucleotide 3’ overhang. Incorporation of the miRNA duplex into the ribonucleoprotein
complex (RISC) is the defining step for silencing. During this step is determined which of the
two strands will be the mature miRNA. Argonaute (AGO) proteins 1–4, main components of the
RISC, guide the endonucleolytic cleavage or translational repression or deadenylation of the target
mRNA. (Figure modified from (Winter et al., 2009).)
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invertebrates (Montgomery and Fire, 1998). The effector molecules are short
21–23 nucleotide double-stranded small interfering RNAs (siRNAs), resulting from
multiple intracellular modifications. Originally, RNAi was recognized as an endoge-
nous regulatory pathway that protects the host organism from viral genomes and
transposons. Soon, this mechanism received enormous attention with the discovery
of miRNAs, that are implicated in the pathogenesis of several diseases, e.g., cancer,
metabolism, and neurodegeneration, through the regulation of gene expression.
Gene silencing (knock-down) has become an attractive tool to manipulate the
expression of genes. Multiple RNAi inducer molecules (siRNA, shRNA, miRNA)
and different viral vector (adeno-associated, adenovirus, lentivirus, retrovirus)
approaches have been developed and used widely in mammalian systems. The
various strategies of silencing aim to mimic the endogenous RNAi pathway (shown
in Figure 1.5) in order to achieve an efficient, long-lasting effect, minimizing the
chances of cellular toxicity and off-target effects (for review see (Liu and Berkhout,
2011).)
The previously described findings about IHC function in the pachanga mouse
mutant, suggested that a relationship between protein levels and physiological func-
tion might exist (Pangršič et al., 2010). Modification of otoferlin protein levels may
result in a variety of physiological responses. The approach of gene silencing is one
possible method to manipulate the levels of otoferlin.
1.6 Aims of this study
While current research has started to elucidate the role of otoferlin at the IHC ribbon
synapse, its precise function(s) are not yet fully understood. Multiple indications
suggest to be the main calcium sensor, participating in a later step of exocytosis. The
levels of the protein at the synapse seem to be critical for its functionality, while in
parallel, evidence on the localization of otoferlin at non-synaptic sites, might suggest
an extra role in endosomal/Golgi trafficking.
The knowledge about the pinball-wizard mutation in zebrafish sets new questions
about the role of this non-synaptic protein into the auditory system. It is quite pos-
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sible that tryptophan-rich basic protein has an indirect role in hearing and rather
governs the fate of otoferlin and/or of other TA proteins. If the biogenesis of otofer-
lin is regulated by the classical posttranslational membrane-insertion pathway of
TRC40, then more light can be shed on the regulation and turnover of otoferlin in
IHCs.
The goal of this thesis is mainly to characterize the physiological function of
WRB in a loss of function mutant. Moreover, in a preliminary attempt, a gene
silencing strategy was designed, for delivery of miRNA-like silencing molecules by
adeno-associated viruses in the developing mouse otocyst.
Using a conditional knockout mouse line, I applied system-, cell physiology, and
morphological approaches to understand the phenotype of the wrb deletion. For the
designing of the silencing strategy, I used molecular and cell biology, in combination






The chemicals used in this study were purchased from BD Biosciences (Germany),
Carl ROTH, Fluka Analytical (SIGMA-ALDRICH Laborchemikalien GmbH Seelze,
Germany), Invitrogen (Darmstadt, Germany), MERCK (Darmstadt, Germany) and
ROCHE (Mannheim, Germany). Amphotericin B, Streptomyces sp., cat. No.
171375, 100 mg was purchased from Calbiochem (Merck KGaA, Darmstadt, Ger-
many).
2.1.2 Enzymes, kits and bacterial strains
All restriction enzymes, DNA and Protein Ladders were purchased from Fermentas-
Thermo Fischer Scientific GmbH (Schwerte, Germany). For DNA gel extraction
reactions, purification of digestion reactions, as well as for proliferations of DNA
plasmids, kits from ZYMO Research (Freiburg, Germany), Peqlab Biotechnologie
GmbH (Erlangen, Germany), and Macherey-Nagel GmbH & Co.KG (Germany) were
used. Amplification of DNA plasmids was performed in Escherichia coli (E. coli)
XL1-Blue, SURE (Stratagene, Agilent Technologies GmbH & Co.KG, Waldbronn),
and DH5α (Invitrogen) bacterial strains.
2.1.3 miRNA sequences and oligomers
Primer design and all the major cloning steps were first simulated and confirmed
using GENtle software (University of Cologne, Germany). Multiple miRNA se-
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quences were designed against the mRNA ofM. musculus otoferlin transcript variant
1 (GenBank accession no. NM 001100395.1), using the algorithms BLOCK-iTTM
RNAi Designer (Invitrogen) and siRNA Wizard v3.1. The final 21mer nucleotide
sequences were tested through a BLAST search to ensure specificity for the target
mRNA. The previously mentioned sequences, as well as all the following described
oligomers, were chemically synthesized by the AGCT Lab in the DNA Core Facility
of the Max Planck-Institute of Experimental Medicine in Göttingen.
2.1.4 Sequencing reactions and viral vector production
Sequencing of the DNA constructs was performed and validated by the AGCT Lab.
The viral vector AAV-HBA-EWB, as well as all the viruses used in this study,
were produced by Dr. Sebastian Kügler from the Viral Vectors Lab, Department of
Neurology, at the University Medicine of Göttingen.
2.1.5 Buffers
Immunohisto-, immunocyto-chemistry
PBS (Phosphate Buffer Saline): 137 mM NaCl, 10 mM Na2HPO4, 2.7 mM, pH 7.4.
PB (Phosphate Buffer): 240 mM Na2HPO4H2O.
GSDB (Blocking solution): goat serum, 0.3% Triton X-100, 240 mM PB, 4 M NaCl.
Wash buffer: 20 mM PB, 0.3% Triton X-100, 450 mM NaCl.
Blocking buffer: 10% goat serum, 0.3% Triton X-100 in PBS pH 7.4.
4% Paraformaldehyde: From a 37% initial stock (Carl ROTH), the final working
concentration that was used was 4% in PBS.
Mowiol Mounting Medium: Dissolve 2.4 g Mowiol 4-88 (Carl ROTH) into 6 g
Glycerol, add 12 ml ddH2O and keep stirring the solution for several hours at room
temperature. Add 0.2 M Tris pH 8.5 and heat the mixture for 1-2 h at 50 ◦C.
When Mowiol is dissolved, the solution is centrifuged at 500 x g for 15 min, add
2.5% DABCO (Carl ROTH) and aliquoted.





RIPA buffer (for mammalian cells): 50 mM Tris-HCl pH 7.4, 150 mM NaCl,
2 mM EDTA, 1% NP-40, 0.1% SDS. On the day of use 1 mM PMSF and
phospatase/protease inhibitors cocktail tablets were added (PhosSTOP and com-
plete ULTRA tablets, Mini, EDTA-free, ROCHE), according to the manufacturer
instructions.
SDS-PAGE
2x Protein Sample buffer: 125 mM Tris-HCl pH 6.8, 4% SDS, 150 mM DTT, 20%
Glycerol, 0.01% Bromophenol blue.
Running buffer: 25 mM Tris-HCl, 192 mM Glycine, 0.1% SDS.
Transfer buffer: 25 mM Tris-HCl, 192 mM Glycine, 20% Methanol.
TBS: 200 mM Tris-HCl pH 7.6, 1,368 mM NaCl.
TBST: 200 mM Tris-HCl, 1,368 mM NaCl, 0.1% Tween 20.
Molecular Biology
11.1x PCR Buffer: 45 mM Tris-HCl pH 8.8, 11 mM ammonium sulphate, 4.5 mM
MgCl2, 6.7 mM 2-mercaptoethanol, 4.4 μM EDTA pH 8.0, 1 mM of each dNTP,
113 μg/ml BSA.
10x Oligo Annealing Buffer (used in annealing reactions of miRNA oligomers):
100 mM Tris-HCl pH 7.5, 10 mM EDTA pH 8.0, 1,000 mM NaCl.
10x TE Buffer: 100 mM Tris-HCl pH 7.5, 10 mM EDTA pH 8.0.
50x TAE DNA Electrophoresis buffer: 2,000 mM Tris-HCl, 50 mM EDTA.
DNA loading dye: 50% Glycerol, 1 mM EDTA pH 8.0, 0.15% Bromophenol blue.
Tissue cultures
2x HBS (HEPES buffered saline): 280 mM NaCl, 10 mM KCl, 1.5 mM Na2HPO4,
12 mM Dextrose, 50 mM HEPES, pH 7. Sterile filtered through 0.22 μm filter.
Cell physiology
HEPES-buffered Hanks balanced salt solution: 5.36 mM KCl, 141.7 mM NaCl, 1
mM MgCl26H2O, 0.5 mM MgSO47H2O, 10 mM HEPES, pH 7.2, ∼290 mOsm. Be-
fore dissection of the organ of Corti 2 mg/ml glucose and 0.5 mg/ml L-glutamine
was added.
Modified Ringers solution (extracellular solution): 2.8 mM KCl, 110 mM NaCl, 1
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mM MgCl26H2O, 35 mM TEA-Cl, 10 mM HEPES, 1 mM CsCl, 2 mM CaCl2, pH
7.2, ∼290 mOsm. Before recordings 2 mg/ml glucose was added.
Intracellular recording solution for perforated patch: 130 mM Cs-gluconate, 10 mM
TEA-Cl, 10 mM 4-AP, 1 mM MgCl26H2O, 10 mM HEPES, pH 7.2 adjusted with
HCl, ∼290 mOsm. On the day of the experiment 300 μg/ml amphotericin B was
added.
Amphotericin stock solution: A stock solution of Amphotericin 50 μg/μl in Dimethyl
Sulfoxide (DMSO, SIGMA-ALDRICH) was prepared every 3 days and 300 μg/ml
were diluted always fresh into 0.5 ml of intracellular solution. The solution was
sonicated thoroughly, protected from light and kept on ice until use.
Genomic DNA genotyping
Genomic Mouse Tail Buffer (GMT): 10 mM Tris pH 8.5, 50 mM KCl, 1.5 mM
MgCl2, 0.01% gelatin, 0.45% igepal 630, 0.45% Tween-20. Freshly added in each
PCR reaction tube 100 μg/ml proteinase K.
2.1.6 Antibodies
Primary
• mouse anti-CtBP2 aa. 361-445, IgG1, cat. No. 612044 (BD Biosciences)
• mouse anti-Otoferlin [clone13A9], cat. No. ab53233 (Abcam, Germany)
• rabbit anti-GFP serum cat. No. 598 (MoBiTec, Göttingen, Germany)
• rabbit anti-glutamate receptor 2 & 3 cat. No. AB 1506 (Millipore,
Merck)
• rabbit anti-VGLUT3 aa. 543-601, cat. No. 135203 (Synaptic Systems)
• rabbit anti-α tubulin aa. 443-449, cat. No. 302 203 (Synaptic Systems)





All the secondary antibodies were Alexa Fluor IgG (H+L), Molecular Probes (In-
vitrogen)
• 488 goat anti-rabbit cat. No. A11008
• 488 goat anti-mouse cat. No. A11001
• 568 goat anti-mouse cat. No. A11004
• 568 goat anti-rabbit cat. No. A11011
• 633 goat anti-rabbit cat. No. A21070
• anti-GFP rabbit Alexa Fluor 488 conjugate cat. No. A21311
2.1.7 Primers
The primers used for genotyping were:
wt forward: 5’-TTGGTGAGGCTTGTCTCTGGCGATTT -3’
wt reverse: 5’-GTTGATCTTCCTTTCCAGCCTGGCGTAT -3’
dneo forward: 5’-AGTGTACACGCGTACTAGTCTAGCGAA -3’
dneo reverse: 5’-ACTCAAAGGCAACAGCCAAGATAAGCA -3’
The primers used for checking the length of the transcript after WRB recombi-
nation were:
wrb exon1 forward: 5’-GTGTTGAGCTTCGTGTTCGG-3’
wrb exon2 reverse: 5’-ACGTGCGTTTTGAGCTTGTC-3’




Animal handling was in accordance with the national animal care guidelines and all
experiments were reviewed and approved by the animal welfare committees of the
University of Göttingen and the State of Lower Saxony.
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2.1.9 Mouse lines
“pinball-wizard (Pwi)”
The conditional mouse line with floxed the WRB (tryptophan-rich basic protein)
gene was kindly offered to us by Professor David Corey (Harvard Medical School)
and Dr. Shuh-Yow Lin (UC San Diego). Briefly, it was produced as follows: the
wild-type WRB genomic locus was targeted by the FRT/loxP recombination system.
The insertion of a neomycin (neo) cassette, flanked by 2 Flp (flippase) Recombina-
tion Target (FRT) sites, served as a selection marker of those embryonic stem (ES)
cells which had properly uptaken the target construct. These ES with resistance
in the antibiotic neomycin were further selected to be injected into the blastocyst
of a pregnant mouse. The offspring with the targeted gene were crossed with a
flippase-expressing mouse line to remove the neo cassette by FRT site-directed re-
combination. In the conditional line, the exons 2-4 of WRB are targeted for excision.
The line is of 129SVEV background. It was kept either in homozygous (Pwiflx/flx)
or heterozygous (Pwiflx/+) breeding for the floxed wrb gene.
“VDCR-CGCT”
The Cre expressing reporter mouse line VDCR-CGCT, was a kind gift from Dr.
Sonja Wojcik (Max-Planck Institute for Experimental Medicine, Göttingen). It
contained two transgenes, independently inherited from each other; the VDCR, in
which a Vglut3 promoter may express the bacterial Cre recombinase gene in those
tissues and cells that express VGLUT3 and the CGCT, in which a constitutive
promoter (CAG) can only guide the expression of the reporter gene EGFP if
homologous Cre recombination removes the stop cassette before EGFP. Due to this
design, the EGFP expression is achieved only when Cre recombinase is active and
only in tissues that express VGLUT3. The VDCR was active in homozygous or
heterozygous state and was abbreviated VDCR+.
The pinball-wizard line was cross-bred with the Vglut3-CRE specific EGFP re-
porter line VDCR-CGCT. Heterozygous or homozygous Wrb floxed, Pwiflx/+ or
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Pwiflx/flx, were initially mated with VDCR+ CGCT+ animals, to obtain all three
transgenes in the same mouse line. The following breedings were performed: Pwiflx/+
VDCR+ CGCT+ mice were mated with Pwiflx/flx VDCR- CGCT+ mice. The off-
spring used were: Pwiflx/flx VDCR+ CGCT+ (KO), Pwiflx/flx VDCR- CGCT+ or -
(control) and Pwi+/+ VDCR+ CGCT+ (control). Pwiflx/flx VDCR- CGCT+ or - con-
trol mice carrying CGCT+ or CGCT- were used and throughout the thesis they
will be symbolized as Pwiflx/flx VDCR- CGCT+. For all the experiments with the
pinball-wizard line, animals of up to two months of age were used.
Otoferlin heterozygous
Otoferlin heterozygous, Otof+/- animals resulted from the breeding of Otoferlin
knock-out (generated by Dr. Ellen Reisinger) with wild-type C57BL/6J. For the
cell physiology experiments on Otof+/-, control measurements were performed on
wild-type C57BL/6J animals.
Viral injected animals
Embryonic transuterine otocyst injections were performed in embryonic day 11.5
(E11.5) embryos of wild-type CD1 female pregnant mice, previously mated with
CD1 males.
All new born animals were genotyped shortly after birth and before each experi-
ment to ensure their identity and plan the downstream experiments accordingly.
2.2 Methods
2.2.1 Cloning procedures
Molecular cloning was performed according to the standardized protocols described
in Molecular Cloning Laboratory Manual, 2nd edition (Joseph Sambrook and David
W. Russell, 1989).
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2.2.2 Cloning of the microRNA expressing vector
The goal was to create a vector, which expresses a miRNA oligomer and to
report this expression by a fluorescent marker. For that, the commercially
available pEGFP-C1 vector (Clontech, TaKaRa Bio Company) was used as the
backbone and the microRNA vector preparation was performed in two consecu-
tive steps. The final product of this procedure was abbreviated pEGFP-C1 miRNA.
Step 1: ’microtemplate’ cassette
First, a microtemplate cassette was introduced into the pEGFP-C1 backbone, as
Figure 2.1 shows. The microtemplate cassette sequence was:
5’-TCGAGCTTAACTGGAGGCTTGCTGAAGGCTGTATGCTGCGGCCGC
CAGGACACAAGGCCTGTTACTAGCACTCACATGGAACAAATGGCCA -3’
TCGAG: XhoI restriction enzyme overhang
CT: linker from pEGFP-C1 vector
TAA: stop codon of EGFP
CTGGAGGCTTGCTGAAGGCTGTATGCT: 5’ flanking region
GCGGCCGC: NotI restriction enzyme
CAGGACACAAGGCCTGTTACTAGCA
CTCACATGGAACAAATGGCC: 3’ flanking region








- TAA - 5’ flanking region - NotI - 3’ flanking region -
A
Figure 2.1: The pEGFP-C1 backbone. Cartoon illustrates the pEGFP-C1 backbone. The
microtemplate casette was introduced between the restriction sites XhoI and HindIII, downstream
of EGFP.
This cassette was introduced in two separate parts. First, the pEGFP-C1 vector
was digested with XhoI and HindIII restriction enzymes for 1 h at 37 ◦C, followed
by 20 min incubation at 80 ◦C for inactivation of the enzymes. Afterwards, the
backbone was dephosphorylated with alkaline phosphatase enzyme for 10 min at
37 ◦C and subsequently incubated for 5 min at 80 ◦C for inactivation of the enzyme.
The product was then loaded on a 1% agarose gel from where the band of interest
was isolated and processed for DNA extraction and purification. The clean product
was eluted in 0.1x TE Buffer. The first half of the microtemplate cassette was then
ligated with the digested backbone for 2 h at room temperature. Phosphorylation
of the endings and oligomer annealing reactions were performed as described later.
first half of microtemplate
5’-TCGAGCTTAACTGGAGGCTTGCTGAAGGCTGTATGCTGCGGCCGCGAGAA -3’
Afterwards the pEGFP-C1 vector containing the first half of the microtemplate
was digested once more with NotI and HindIII restriction enzymes for 1 h at 37 ◦C
with 1x Tango buffer and then for an additional 1 h with 2x Tango buffer and
purified as described previously. The second half of the microtemplate cassette was
then ligated with the digested backbone. The resulting pEGFP-C1 microtemplate
vector was sequenced to confirm the correct insertion of the microtemplate.
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second half of microtemplate
5’-GGCCGCCAGGACACAAGGCCTGTTACTAGCACTCACATGGAACAAATGGCCA -3’
The termini of 50 μM forward and 50 μM reverse strand of each oligomer
were phosphorylated using 10 Units of T4 PNK enzyme, T4 PNK Buffer A
10x and 10 mM ATP for 30 min at 37 ◦C. An additional 5 min incubation
time at 75 ◦C was used for deactivation of the enzyme. Then they were heated
at 95 ◦C for 4 min and left to anneal slowly while cooling down at room temperature.
Step 2: miRNA oligomer
Every miRNA oligomer (from 5’ to 3’) consisted of: the restriction enzyme NotI
overhang, the reverse compliment of the 21mer miRNA sequence, the miRNA loop
sequence, the 1–8 and 11–21 nucleotides of the 21mer sequence and again the
restriction enzyme NotI overhang. All of them were phosphorylated and annealed
as described before and further subcloned inside the microtemplate cassette of the
pEGFP-C1 vector. Digestion of the pEGFP-C1 vector was done by using the NotI
restriction enzyme and ligation with the miRNA oligomer was achieved after 2 h
at room temperature. The resulting pEGFP-C1 miRNA vectors were sequenced to
confirm the correct insertion of the miRNA oligos.















The 21mer miRNA sequences used were:
miRNA1 (3969-3989 bp of NM 001100395.1):
5’-AAACTGGATGCGACTTCTGAT -3’
miRNA2 (1985-2005bp of NM 001100395.1):
5’-CACAGGGAGAATGGAAGAATT -3’
control sequence 1 (scrambled sequence of NM 001100395.1):
5’-ATTGGAATATCCGCTTGACCA-3’
control sequence 2 (scrambled sequence of NM 001100395.1):
5’-ATTGGAACTGAGTCGTAGTGA-3’
2.2.3 Cloning of the AAV1/2 -HBA-EGFP-miRNA vector
In order to in vivo silence the protein of our interest, a viral vector able to transduce
inner hair cells and express the different miRNAs was created. This viral vector
expressed the whole microtemplate cassette with the different miRNA oligos tagged
to a fluorescent reporter. The backbone AAV1/2-HBA-EWB viral vector was
kindly provided by Dr. Sebastian Kügler. It contained inverted terminal repeats
(ITRs) of the adeno-associated virus (AAV) serotype 2, the human cytomegalovirus
(CMV) enhancer combined with the human actin promoter (HBA), an eGFP
(enhanced GFP) reporter protein, a woodchuck posttranscriptional regulatory
33
2. Materials and Methods
element (WPRE), and a bovine growth hormone (BGH) polyadenylation sequence.
It expressed a chimeric capsid from the serotype 1 and 2.
The backbone, as well as the pEGFP-C1 miRNA vector, were digested with NheI
and HindIII restriction enzymes. The bands of interest from the backbone and
the miRNA vector were purified from an agarose gel and ligated for 3 h at room
temperature. The ligated vector was then concentrated by ethanol precipitation
before amplification into SURE electrocompetent bacteria. The final viral product
was sequenced to ensure the correct insertion of the miRNA oligo and amplified in
E. coli bacteria.
2.2.4 Ethanol precipitation of DNA
The ligated product of the AAV1/2 -HBA-EGFP-miRNA vector was incubated for
2 days in −20 ◦C with 1:10 volume of NaOAc 3 M, 1 μl glycogen and 100% ethanol.
Then, it was centrifuged at 13,000 rpm at 4 ◦C for 1 h and the pellet was washed
with 70% ethanol. The residual ethanol was removed by centrifugation, the DNA
pellet was air-dried and was resuspended in ddH2O.
2.2.5 Bacterial transformation
Chemical transformation
The DNA was amplified in E. coli, DH5α, and XL-1 Blue chemical competent bac-
terial strains. Generally, the amount of DNA mixed with bacteria was varied. DNA
0.5 μl - 5 μl was mixed with 50 μl bacteria and incubated on ice 30 min. Afterwards,
it was transferred at 42 ◦C for 2 min and then placed on ice for additional 2 min.
LuriaBroth medium 800 μl was added and the bacteria containing the DNA were
incubated while shaking for 1 h at 37 ◦C at 250 rpm. At the end of the incubation
the mixture was centrifuged, most of the supernatant was discarded and the pellet
was resuspended in a remaining volume of 30 μl. The resuspended bacteria were
plated on agar antibiotic-specific plates and antibiotic-resistant colonies were let to
grow overnight. Next day clones of successfully transformed bacteria were picked
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up and let further grow for 16 h at 37 ◦C at 250 rpm. DNA was isolated and purified.
Electrical transformation
For the amplification of viral vectors the electroporation-competent bacteria cells
SURE were used. 50 μl were mixed with 0.5-1 μl viral plasmid DNA in a pre-chilled
cuvette (Gene Pulser 0.1 cm BIO-RAD). The bacteria were electroporated at the
Biorad Gene Pulser II at V = 1.7 kV, to uptake the viral DNA. Immediately after
the pulse, the cells were transferred into an eppendorf tube and 800 μl Luria Broth
medium was added. The mixture was processed the same way as described above
and then, it was let grow overnight on agar plates with the antibiotic Carbenicillin
(50 mg/ml). The antibiotic-resistant bacterial colonies were processed as previously
described.
2.2.6 Cell Culture
Human embryonic kidney (HEK 293T) cells were grown in Dulbeccos modified
Eagles medium (DMEM from Invitrogen) supplemented with 10% fetal calf serum
(FCS), 100 U/ml mixture penicillin/streptomycin and incubated at 37 ◦C with 5%
CO2. They were passaged when they reached confluency, normally every 4 days.
For this process the medium was removed, a single wash with 5 ml pre-warmed
PBS was done and then 2 ml of pre-warmed (37 ◦C) Trypsin/EDTA solution was
added to the culture dish for detaching the cells. The trypsin activity was stopped
by addition of DMEM. The cells were carefully transferred to a 15 ml Falcon tube
and were centrifuged for 5 min at room temperature at 2.500 rpm. The pellet was
resuspended in fresh DMEM and the cells were seeded in new culture dishes (Cell
Star Greiner bio-one, Solingen, Germany). They were used until their 20th passage.
2.2.7 Cell Transfection Methods
For downstream immunocytochemistry experiments, the cells were grown on
coverslips first washed with 70% ethanol and then coated with 0.01% poly-L-lysine
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ready-to-use solution (SIGMA-ALDRICH). After 20 min incubation with poly-L-
lysine, the solution was removed and cells were plated directly on the coverslips.
Lipofection
The cells were plated one day prior transfection in 6-well plates or 24-well plates
in normal DMEM supplemented with 10% fetal calf serum (FCS) and 100 U/ml
mixture penicillin/streptomycin. One hour before transfection the medium of the
cells was changed to Opti-MEM (Invitrogen). For one well of the 24-well plate
0.8–1 μg DNA was diluted in 50 μl OptiMEM and separately 1–2 μl Lipofectamine
2000 (Invitrogen) in 50 μl OptiMEM. After 5 min incubation, the two solutions
were mixed and 20 min later the transfection mix was added to the well. For one
well of the 6-well plate, 4 μg DNA was diluted in 250 μl OptiMEM and separately
10 μl Lipofectamine 2000 (Invitrogen) in 250 μl OptiMEM. For double plasmid
transfections 6-well plates were used and the ratio of the two plasmids varied,
always keeping a total maximum amount of 8 μg DNA and 12 μl Lipofectamine
per well. The transfection mix was removed 6 h after and replaced with normal
DMEM. Cells were processed 48 h post-transfection.
Calcium phosphate
The cells were plated one day prior transfection in 6-well plates or 10 cm cell
culture dishes, waiting for 60–70% confluency until the transfection. For 1 well
of the 6-well plate, 3 μg DNA were diluted with 20 μl CaCl2 2.5 M solution in a
final volume of 85 μl (Solution A). The Solution A was added dropwise to 85 μl
2x HBS (Solution B). For a 10 cm cell culture dish the Solution A consisted of
15 μg DNA, 90 μl CaCl2 and 645 μl ddH2O. The Solution B consisted of 750 μl
2x HBS. The mix of the two solutions was mixed vigorously and left for 2 min at
room temperature to allow the DNA-CaCl2 complexes to form. Then it was added
in fresh DMEM medium supplemented with 2% FCS and finally added to the cells.
The transfection mix was removed 4 h later and replaced with normal DMEM.
Cells were processed 48 h post-transfection.
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2.2.8 Preparation of protein lysates
Cell protein lysates
Transfected cells were processed 24–48 h after transfection. The culture medium
was removed from each plate or well and washed with icecold PBS. The cells were
collected in RIPA buffer, containing protease and phosphatase inhibitors, with a
plastic scraper and further lysed by triturating them three times through a 27G
needle. The lysate was centrifuged for 45 min at 10,000 rpm and the supernatant
was kept for western blot.
2.2.9 Protein concentration estimation
Protein concentration of every cell lysate or tissue sample was determined using the
Bradford colorimetric protein assay (SIGMA-ALDRICH). Six different dilutions
(0, 2.5, 5, 10, 15, 20 mg/ml) of 1 μg/μl Bovine Serum Albumin (BSA, purified
100x, 10 mg/ml, New England BioLabs Inc.) were prepared, adding RIPA buffer
and Bradford Reagent. These standards were prepared in triplicates, measured in
a SmartSpec Plus Spectrophotometer (Biorad) and the protein absorbance at 595
nm determined the concentration. From the values, a standard curve of protein
concentration was designed. The concentration of the protein was estimated by the
standard curve.
2.2.10 Western Blotting
Samples were separated in a 8% (denaturating) Tris-HCl SDS polyacrylamide
gel electrophoresis system. The resolving gel consisted of 8–10% bis-acrylamide
(Rotiphorese Gel 30, Roth GmbH, Karlsruhe, Germany), 1 M Tris (pH 8.45),
0.1% SDS, 10% glycerol; the stacking gel contained 4% bis-acrylamide, 1 M
Tris (pH 8.45), 0.1% SDS. Ammonium persulfate and TEMED (N, N, N’, N’-
Tetramethylethylenen-diamine) were added for polymerization. 1:5 2x Protein
Sample buffer was added to the samples and they were boiled for 5 min. 20–50 μg
of protein were loaded to the gel together with 5μl PageRuler prestained protein
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ladder solution (Fermentas) for approximate the size of the proteins. The SDS gels
ran for 1 1/2 h at 90 V. Subsequently, proteins were transferred either to Amersham
HybondECL nitrocellulose membrane (GE Healthcare) or to Immun-Blot PVDF
0.2 μm via dry blotting system Mini Trans-Blot Cell (BIO-RAD). For the transfer
of the proteins, 220 mA were applied per blot for 4 h in a Biorad PowerPac 300
blotting apparatus. The membranes were blocked for 1 h at room temperature
in blocking solution (TBS pH 7.4, 5% non-fat milk powder, 0,1% Tween 20) and
then incubated overnight with the appropriate dilutions of the primary antibody
in blocking solution, at 4 ◦C. After 3 washes of 10 min each with TBST, the
blots were incubated with horseradish peroxidase-conjugated secondary antibodies
(diluted 1:5,000), for 1 h at room temperature. Protein bands were detected using
the enhanced chemiluminescence (ECL) system (Pierce ECL Western Blotting
Substrate, Pierce) in a NTAS ChemoCam (NTAS Science Imaging Instruments
GmbH, Göttingen). For the calculation of each band intensity the ImageJ macro
routine “Gel Analysis” was used. Each band of interest was manually selected and
an intensity profile for every band was generated by the macro. The background
intensity was calculated in the immediate vicinity of the band and was substracted
from the bands intensity value. For all the samples quantified, the levels of the
protein of interest in every treated condition were normalized to the levels of protein
of interest in the untreated sample and were set to 100%.
2.2.11 Viral transduction of HEK 293 cell line
The cells were plated one day prior to viral transduction in 24-well plates on
poly-L-lysine coated coverslips (12 mm) as described previously (section 2.2.7)
and in fresh DMEM medium supplemented only with 5% FCS. After 24 h the
medium was removed, the cells were washed once with pre-warmed PBS and 300 μl
transfection mix was added to each well. The preparation of the transfection mix
was done as follows: the desired amount of virus for each well was mixed with 300
μl of DMEM and 5% FCS inside a 1.5 ml eppendorf tube containing a removable
filter of 0.22 μm pore diameter. The mix was centrifuged for 1 min and passed
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through the sterile filter. It was then added to the cells, kept for a maximum period
of 4 days and then removed and the cells were kept for maximum another 2 days
in DMEM and 5% FCS. To optimise the viral transduction efficiency, different
concentrations of each virus were used, varied between 108 tu/μl–4x108 tu/μl,
where tu/μl means transfection units per μl and corresponds to the titer unit of the
virus. The efficiency was indicated by the fluorescent reporter protein that these
viruses were expressing. The cells were observed every 24 h post transduction for
their fluorescent signal and processed by immunocytochemistry when no further
fluorescent difference was obvious.
2.2.12 Embryonic transuterine otocyst injections
This protocol has been thoroughly described in (Reuter, 2011). In this study
injections were performed, using the exact same protocol by the technical assistant
Christiane Senger-Freitag. Wild-type pregnant mice of CD1 genetic background
at postcoidal day 11.5 were used for injections. The newborn pups were used at
post-natal days 7–17 for immunohistochemistry experiments.
2.2.13 Genotyping protocol of the pinball-wizard line
Genomic DNA from KO and WT animals was isolated from their tales. For every
sample, a small part of the tail together with 200 μl GMT buffer were placed in an
eppendorf tube. For lysis, the sample was incubated at 55 ◦C for 2 h to overnight.
Proteinase K was heat-inactivated at 95 ◦C for 10 min and the mixture was briefly
centrifuged to seperate debris from genomic DNA in supernatant. PCR reaction
was set for 2 μl of every sample with 0.5 μl Titanium Taq Polymerase (Invitrogen)
and 10x of the corresponding buffer, 2.5 mM dNTPs and 10 μM of each primer.
Denaturation was at 94 ◦C for 1 min, primer annealing and extension at 94 ◦C for
20 s, 61 ◦C for 20 s, and 68 ◦C for 30 s, repeated for 30 cycles. Final elongation was
achieved at 68 ◦C for 10 min. The PCR product was loaded on a 2% agarose gel
and run for 1 h at 100 V.
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2.2.14 Whole-mount preparation of the organ of Corti
Mice of postanatal day 14 (P14)-P50 were anesthetized with CO2 and killed by
decapitation. The skin of the head was removed and the skull was cut in half along
the midsagittal line and transferred into HEPES-buffered Hanks balanced salt
solution. The brain was removed revealing the temporal bone and the labyrinth
was twisted out in order to expose the cochlea. Through an opening on the apical
part of the cochlea the organ of Corti was revealed and carefully the apical coil was
removed away from the modiolus.
2.2.15 RT-PCR
PCR was performed on cDNA of adult animals (P25) Pwi. For every sample,
4 apical turns (2 animals) of Corti organs were dissected and homogenized into
TRizol Reagent (Invitrogen) with a glass Teflon homogenizer. 200 μl chloroform
were added and after centrifugation for 15 min at 13,300 rpm at 4 ◦C, the upper
aqueous phase of RNA was isolated. To the RNA, 1 μl glycogen and 250 μl
isopropanol were added and was precipitated overnight at −20 ◦C. Purification of
RNA was achieved after another centrifugation for 45 min at 13,300rpm at 4 ◦C
and wash with 75% ethanol. Finally, it was resuspended in ddH2O.
The isolated RNA was reverse transcribed by adding 9 U/μl Superscript II reverse
transcriptase (Invitrogen), 1.1 pM/μl oligo dT (Invitrogen), random hexamers
(Roche), 0.45 nM/μl dNTPs (Invitrogen), 9 nM/μl DTT (Invitrogen) and 1.8 U/μl
RNaseOUT (Invitrogen) with the following protocol: 10 min room at temperature,
30 min at 37 ◦C , 60 min at 42 ◦C and 5 min at 70 ◦C. The cDNA was then used as
template in PCR. The PCR was prepared in final volume 10 μl with 700 ng DNA,
5 μM of forward and 5 μM of reverse primer, 11.1x Buffer, and 2.5 U Platinum Taq
DNA Polymerase (Invitrogen). The amplification of the transcripts was performed
at 36 cycles at the following program: initial denaturation at 94 ◦C for 5 min,
denaturation at 94 ◦C for 1 min, primer annealing at 57 ◦C for 30 s, and elongation
40
2.2 Methods
at 72 ◦C for 1 min, final elongation at 72 ◦C for 7 min. The PCR products were
loaded on a 1% agarose gel with the 100 bp Plus GeneRuler DNA Ladder (cat.
No. #SM0321/2/3, Fermentas). Water sample was used as negative control and as
positive control, parvalbumin was amplified in all samples.
2.2.16 Perforated patch-clamp recordings
The electrophysiology experiments were performed on whole-mount preparation of
the apical coil of the organ of Corti isolated in HEPES-buffered Hanks balanced
salt solution. Each explant was transferred inside a recording chamber and fixed
at the bottom with a grid of nylon threads, with the tectorial membrane facing
upwards. The tissue was constantly perfused during recordings with Modified
Ringers solution at a rate of at least 0.5 ml/min. In order to gain access to the
lateral membrane of the IHCs, the tectorial membrane, the three rows of the OHCs,
the outer pillar, inner pillar and phalangeal cells were removed, using soda glass
pipettes.
The patch-clamp setup was shielded by a Faraday cage, assembled on a hydraulic
air table for vibration isolation (TMC, Peabody, USA) and consisted of an upright
Olympus BX50WI microscope (Olympus, Hamburg, Germany) equipped with
60x/0.90 W LUMPlanFI objective. The bath level inside the recording chamber
and the pipette pressure were controlled by a pump, the Ringer-Bath-Handler
(Lorenz Messgerätebau GmbH, Katlenburg-Lindau, Germany). The tissue was
visualised by the software Vision, version 4.0 (1996-2005 TILL Photonics GmbH,
München). The pipette movement was under control of a step-motor micromanipu-
lator (SM-5, Luigs & Neumann, Ratingen, Germany). The electrical input/output
was performed with a EPC-9 HEKA amplifier controlled by the Pulse software
(HEKA, Lambrecht/Pfalz, Germany).
The perforated patch-clamp recordings were carried out essentially as described by
(Sakmann and Neher, 1984). Prior to filling with the intracellular-containing ampho-
tericin solution, the tip of the recording pipette was dipped into amphotericin-free
solution, to prevent from release of the antibiotic into the extracellular environment
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of the cells. The recording pipette was made of GB150-8P borosilicate glass
capillaries (Science Products, Hofheim, Germany), pulled at a Sutter P-2000 laser
pipette puller (Sutter Instrument Company, Novato, USA), having a resistance of
∼4.5 MΩ. It was positioned close to the IHC under constant positive pressure of
∼2.7 cm H2O to avoid blockage of the pipette tip. After making contact with the
membrane of the IHC, a gigaseal was established by application of slightly negative
pressure through the recording pipette. The time needed for amphotericin to diffuse
towards the tip and perforate the membrane of the IHC was estimated between
10–20 min. The recordings started when series resistance was ∼30 MΩ. Membrane
capacitance was measured with the Lindau-Neher technique (Lindau and Neher,
1988). ΔCm was estimated as the difference of the mean Cm over 400 ms after
the end of the depolarization, skipping the first 80 ms, and the mean pre-pulse
Cm over 400 ms. Currents were leak corrected with a p/4 protocol. Data anal-
ysis was performed using Igor Pro software (Wave-Metrics, Lake Oswego, OR, USA).
2.2.17 Immunostaining
Immunohistochemistry
The whole-mount organ of Corti was fixed in 4% formaldehyde (FA) diluted in PBS
for either 1 h or 10 min on ice. Alternatively, the tissue was fixed in methanol at
−20 ◦C for 20 min. The fixative was removed by washing the tissue several times
in PBS. Blocking was performed in GSDB at room temperature for 1 h and was
followed by primary antibodies incubation diluted in GSDB at 4 ◦C overnight. The
next day, the tissue was washed in Wash buffer and incubated with the secondary
antibodies for 1 h at room temperature, also diluted in GSDB. Finally, the tissue
was washed three times in Wash Buffer before mounted on glass slides in Mowiol
4-88 mounting medium.
Immunocytochemistry
HEK 293 cells were grown on poly-L-lysine coated coverslips. On the day of im-
munostaining, they were washed once with ice-cold PBS and subsequently fixed for
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20-45 min in 4% formaldehyde (FA) in PBS. The coverslips were washed three times
in PBS and incubated in the Blocking buffer for 45 min followed by overnight incu-
bation at 4 ◦C into the primary antibody, which was diluted in 5% goat serum and
0.1% Triton X-100 in PBS. The coverslips were washed in PBS and incubated for
an additional 1 h at room temperature with the secondary antibody. Finally, they
were washed and mounted on glass slides in Mowiol 4-88 mounting medium.
2.2.18 Confocal microscopy and image analysis
Antibody-stained samples were imaged on a laser-scanning Leica SP2 confocal mi-
croscope using a 10x air and/or a 63x 1.4 NA oil-immersion objectives, with a blue
argon 488 nm laser, a green HeNe (Helium Neon) 561 nm and a red HeNe 633 nm
laser (Leica Mikrosysteme, Wetzlar, Germany). The vertical step size for Z-stack
acquisitions was 0.5 μm. Acquisition was performed using the sequential line mode,
so that the images from two different channels were perfectly aligned. Image anal-
ysis was performed with ImageJ and a Matlab (The Mathworks Inc., Natick, MA,
USA) custom-written routine (Dr. Tina Pangršič). For the semi-quantification of
otoferlin protein levels the Matlab routine calculated the fluorescent signal of max-
imum confocal projections of the two channels, otoferlin and VGLUT3. Polygonal
regions of interest (ROI) were manually set on every individual IHC, one in apical
and one in basal region of the IHC. The mean fluorescent intensity of each chan-
nel was calculated after subtracting the background fluorescence outside hair cells.
The averages were calculated separately for apical and basal parts of the cells. The
fluorescence data were then normalized to the fluorescence observed in IHCs from
Pwi+/+ VDCR+ CGCT+.
2.2.19 Electron Microscopy
The electron microscopy was performed by Dr. Carolin Wichmann. Mouse cochleae
of 21 post-natal days were explanted and fixed by perfusion for 1 h on ice with
4% PFA and 0.5% glutaraldehyde in 1x PBS of pH 7.2. Afterwards the apical
turns of the organs of Corti were isolated and fixed further overnight on ice with
2% glutaraldehyde in 0.1 M sodium cacodylate buffer of pH 7.2. The epithelia were
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washed in sodium cacodylate buffer and placed in 1% osmium tetroxide ((v/v) in 0.1
M cacodylate buffer) on ice for 1 h for further fixation, followed by 1 h washing step
in sodium cacodylate buffer and three brief washing steps in ddH2O. The epithelia
were prepared as samples en bloc and stained again with 1% (v/v) uranyl acetate
in ddH2O for 1 h on ice. After a brief wash in ddH2O, the samples were dehydrated
at room temperature in increasing ethanol concentrations, infiltrated in Epon resin
(100% EtOH/Epon 1:1 (v/v), 30 and 90 min; 100% Epon, overnight) and embedded
for 48 h at 70 ◦C. The embedded samples were sliced from the anterior edge in 65-
75 nm sections. The sections were stained with 4% uranyl acetate and Reynold’s
lead citrate (Reynolds, 1963). Micrographs were obtained with a JEOL electron
microscope (JEM 1011) (JEOL Germany GmbH) equipped with a Gatan Orius
1200A camera (Gatan GmbH, München, Germany) using the Digital Micrograph
software package.
2.2.20 Auditory Brainstem Responses
The ABR recordings were performed by Nadine Hermann. The animals were anes-
thetized with a combination of ketamine (125 mg/kg) and xylazine (2.5 mg/kg)
injected intraperitoneally. The heart rate was monitored to control for the depth
of anesthesia. If necessary the anesthesia was maintained by additional injection
of 0.35–0.75 mg ketamine every 30 to 90 min. The animal was kept at a constant
temperature of 37 ◦C on a heated pad. Upon the absence of the toe reflex after
induction of anesthesia, three needles were inserted under the skin of the animal;
the active electrode was positioned behind the ear (mastoid muscle), the reference
electrode in the midline (vertex) of the head and the ground electrode near the tail.
For stimulus generation and data acquisition, the TDT System III (Tucker Davis
Technologies) run by BioSig32 (Tucker Davis Technologies) software was used. In
order to determine the hearing thresholds of control and mutant mice, pure tones
(4/6/8/12/16/24/32 kHz, 10 ms plateau, 1 ms cos2 rise/fall, intensities provided as
dB SPL root mean square) were played to the anesthetized animal at a stimulus rate
of 40 Hz and different intensities (10 dB steps) with a maximum of 90 dB. For Click
stimuli we determined the changes in amplitudes and latencies of all ABR peaks over
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the entire intensity range between threshold and 120 dB SPL. The speaker was cal-
ibrated with a 1/4 inch Brüel and Kjr microphone (model 4939). At and above the
hearing threshold of the mice the synchronous neuronal activity of the succeeding
nuclei in the auditory pathway display a characteristic series of five waves (forming
a waveform) which were recorded as the 50,000 times amplified difference potential
between vertex and mastoid needles (filtered at 4 kHz low pass and 100 kHz high
pass, averaged 1,300 times). The lowest SPL generating a reproducible wave, clas-
sified by visual judgement of two independent experienced researchers, was defined
as the ABR threshold.
2.2.21 Distortion Product Otoacoustic Emissions (DPOAE)
The function of OHCs was assessed by recording distortion product otoacoustic
emissions. DPOAEs are sounds produced by the cochlea, and more specifically by
the OHCs, in response to an acoustic stimulation. Thus, this test allows testing
the active sound amplification process in the cochlea. The DPOAEs were usually
recorded in the same animals as the ABRs. A custom-made probe containing a
MKE 2 microphone (Sennheiser, USA) and an ED1/EC1 speaker system (Tucker
Davis Technologies) was positioned in the ear canal. A Technics SL-P320 CD
player was used to generate two primary tones f1 and f2 with ratio f2 = 1.2f1 which
were intensity-adjusted using a custom-designed mouse ear coupler and a 1/4 inch
Brüel and Kjr microphone (model 4939) and sound attenuators (TDT System II).
Oto-acoustic emissions were measured after playing 5 different frequency combina-
tions, with f1 being 10 dB lower than f2. Every frequency combination was played
for 32 sec and tested from 10 dB to 60 dB with a step of 10 dB. Calibration used
a mouse ear coupler to predict the SPL at the ear drum. The microphone signal
was digitized using a TerraTec DMX 6fire USB soundcard and Sony SoundForge





3.1 Characterization of the Pwi mouse phenotype
3.1.1 The transgenic Pwi mouse line
An insertional mutagenesis screen in zebrafish (Gross et al., 2005) revealed a va-
riety of pathological phenotypes with defects in the development and function of
the visual system. One of the identified disrupted genes was pwi, later found to
be homologous to the human WRB gene (Murata et al., 2009). The human gene
was initially identified to encode a protein with a tryptophan-rich carboxyl-terminal
region, named WRB (Egeo et al., 1998). Fish, carrying a mutation in the wrb gene
further displayed a balance and hearing (Lin et al., unpublished). This finding mo-
tivated the design of a transgenic Wrb mouse line to study the function of the WRB
protein in mammals with particular focus on its role in hearing.
The Wrb wild-type gene contains 5 exons and the protein has three predicted trans-
membrane domains and one coiled-coil domain directed toward the cytosol (Vilardi
et al., 2011) (see Figure 3.1 A, first row). To enable a conditional deletion of this
protein, loxP sequences have been inserted between exons 1 and 5 (Figure 3.1 A,
second row). I received the conditional Wrb knockout mice (Pwiflx/flx) (Figure 3.1
A, third line) and performed crossings with the VDCR-CGCT strain (Figure 3.1
B). This mouse strain contains a transgene (VDCR) that expresses Cre under Vg-
lut3 -specific promoter, and a transgene (CGCT) that expresses the enhnaced green
fluorescent protein - EGFP, as Cre reporter (generated by Dr. Sonja Wojcik). Since
I was particularly interested in the effects of the deletion of Wrb at the IHC synapse,
the VDCR-CGCT line was chosen to specifically activate Cre recombinase in cells
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Figure 3.1: Targeted disruption of the Wrb gene locus. (A) Maps of the wild-type Wrb
genomic locus, the targeted Wrb gene, the conditional Wrb floxed construct after Flippase homol-
ogous recombination and the predicted structure of the recombined Wrb locus after homologous
Cre recombination and excision of exons 2–4. The diagram shows (from top to bottom) the tar-
geting strategy followed for generation of the conditional pinball-wizard KO mouse line. Initially,
the wild-type Wrb genomic locus was targeted by the FRT/loxP recombination system. Insertion
of a neomycin (neo) cassette, flanked by Flp (flippase) Recombination Target (FRT) sites, served
as selection marker of embryonic stem cells to be used for injection into blastocyst of pregnant
mouse. The offspring with the targeted gene were crossed with a flippase-expressing mouse line
to remove the neo cassette by FRT site-directed recombination. (B) The two transgenes of the
VGlut3 -CRE specific EGFP reporter line VDCR-CGCT. Cre-directed homologous recombination
at loxP sites of the conditional Wrb floxed construct and removal of the stop cassette before EGFP
gene enables Wrb deletion with concomitant EGFP expression in tissues expressing VGLUT3. (C)
The three mouse genotypes used in this study, Pwiflx/flx VDCR+ CGCT+ (KO) (in violet), control
Pwi+/+ VDCR+ CGCT+ (in green) and control Pwiflx/flx VDCR- CGCT+/- (in gray), referred as
Pwiflx/flx VDCR- CGCT+ in the rest of the results.
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expressing VGLUT3. In addition to the cells of interest (IHCs), VGLUT3 is
further expressed in the brain in glutamatergic, cholinergic, serotoninergic, and
GABAergic synapses (Fremeau et al., 2001). Additionally, VGLUT3 can be found in
retina, heart, liver, and kidney (Munguba et al., 2011), thus exposing these tissues to
Cre recombinase activity and potential defects caused by the conditional knockout
(KO) of the WRB protein in our mouse line. The resulting genotypes of the newWrb
mutant mice (Pwi further on) are shown in Figure 3.1 C. In the Pwiflx/flx VDCR+
CGCT+ (KO) mice homologous recombination disrupts the Wrb gene, which is be-
ing reported by EGFP positive IHCs. Throughout this thesis the results obtained
in the KO animals are represented in violet colour. Pwi+/+ VDCR+ CGCT+ mice
serve as one control group and are symbolized by green colour. Pwiflx/flx VDCR-
CGCT+ and Pwiflx/flx VDCR- CGCT- mice (from now on for simplification com-
bined and together denoted as Pwiflx/flx VDCR- CGCT+) are considered as a second
control group, since in the absence of Cre recombinase neither the Wrb construct
nor the CGCT can be recombined. The results obtained in these mice are shown in
gray/black colour (Figure 3.1 C). The conditional Wrb construct should not disrupt
the genomic locus of Wrb and is not expected to cause any deletion of the protein
when not recombined.
3.1.2 The conditional Pwi knockout exhibits seizure-like events
The conditional Pwi KO mice were smaller in size than both control littermates and
frequently trembled and showed a tendency to lean toward the side. In many cases,
the KO adopted a crooked body posture and hit its head against the cage walls. The
KO animals typically died within 2 months after birth. The most striking aspect of
the obvious behavioral phenotype of the KO were episodes of neurological attacks
resembling epileptic seizures. The animals were suddenly stiffened up, loosing bal-
ance and probably consciousness and then, they were beginning to jerk, with rapid
body movements and high tension in the body muscles. Whenever possible, videos
of such events were recorded and examples of the animal’s struggling can be seen in
Figure 3.2. Attacks were initiated without any known reason and lasted for several
minutes.
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Figure 3.2: The behavior of the conditional Pwi KO mice. Snapshots from video recorded
during a presumable epileptic episode of a Pwiflx/flx VDCR+ CGCT+ animal.
Animals showing this behavior were sacrificed to avoid further suffering. Whether
every KO animal experiences at least once epileptic seizure is not known. If epileptic
attacks are the cause of death is also not yet clear. None of the two controls was
ever reported to show a similar behavior. They also had a normal life expectancy.
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3.1.3 Deletion of Wrb causes a progressive hearing defect
Since hearing is impaired in pwi zebrafish mutant (Lin et al., unpublished), I asked
whether the absence of WRB protein also affects hearing of the conditional Pwi KO
mouse and whether it does so in an age-dependent manner. To answer this question,
I selected three age groups and the audiologist Nadine Hermann performed auditory
brainstem response (ABR) recordings. The age groups were selected according to
the following criteria: the first group (group I) included juvenile mice from P14–P19,
which developmentally follows the onset of hearing in mice (P12) (Mikaelian and
Ruben, 1965). Therefore, this is an interesting time-point, since the auditory system
is still under maturation. An additional advantage of choosing this age group is that
it allows for direct comparison to the electrophysiology data, which will be described
in a later section (3.1.6). The second group (group II) consisted of 3- to 4-week old
mice (P21–P29), which, according to our knowledge on wild-type (WT) C57Bl/6J
mice, have a mature auditory function. The last group (group III) consisting of
animals older than 30 days (>P30) was selected to test for possible further deteri-
oration of hearing in the KO animals shortly before their death. Animals from all
three genotypes (Pwiflx/flx VDCR+ CGCT+, Pwiflx/flx VDCR- CGCT+, and Pwi+/+
VDCR+ CGCT+) in all age groups were tested for the auditory system function.
ABR recordings provide information about the response of the auditory pathway
to various stimuli and provide estimates of hearing threshold. Sound stimuli elicit
characteristic waveforms of the difference potential between mastoid and vertex, as
can be seen in Figure 3.3 A. The two control groups showed normal ABR waveforms
in response to the 80 dB SPL click stimulus with comparable amplitude and latency
at all 3 selected ages. However, in the KO mice, a response to sound was observed
only in the youngest age group (group I), where however wave I could not be elicited
and wave III showed a reduced amplitude. At later ages (group II and III) no ABR
activity could be detected.
Another interesting observation that can be made from the ABR waveform graphs
is the occurrence of a low peak or a hump just before wave I, which represents the
summating potential. The summating potential, or receptor potential, is derived
from the combined electrical response of IHCs and OHCs to sound stimulation and
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Pwi CRE- EGFP+/-  (n =5)
Pwi CRE+ EGFP +  (n = 10)
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Figure 3.3: Assessment of hearing in Pwi mouse line. (A) Averaged ABR waveforms of each
genotype in response to 80 dB SPL click stimuli. In goup II and III no ABR responses can be
evoked in Pwiflx/flx VDCR+ CGCT+ animals. Note a noticeable hump at the beginning of the
response in the ABR trace of the Pwiflx/flx VDCR+ CGCT+ animals of group I and II that likely
represents the summating potential of hair cells and disappears in the age group III. (B) ABR
audiograms with the average hearing thresholds for every genotype. Arrows with numbers show
the percentage of animals in which hearing threshold could not be reached within the range of our
recording equipment (up to 90 dB SPL). Data in A and B are presented for three different age
groups, n shows the number of animals recorded.
indicates the presence of at least partially functional mechanotransduction in hair
cells. The KO mice exhibit a summating potential mostly in group I, less in group
II, and not at all in group III. The average hearing thresholds (mean ± s.e.m.)
for all age groups are presented in Figure 3.3 B, with arrows indicating animals
with immeasurable hearing thresholds (> 90 dB SPL). Technical limitations of the
recording system did not allow for detection of responses elicited with sounds of






































Figure 3.4: Assessment of Hearing–DPOAE. (A) Representative power spectrum of the mi-
crophone signal with the two primary tones (f1 and f2 at 60 dB SPL) played at the ear canal of
the mouse during distortion product otoacoustic emission (DPOAE) recordings. (B) DPOAE am-
plitudes in mice of the age group II. As controls, Pwi+/+ VDCR+ CGCT+ and Pwiflx/flx VDCR-
CGCT+ animals were taken (Pwiflx/flx VDCR+ CGCT+ n = 5, controls n = 5).
The arrows symbolize this and the values next to them represent the percentage
of animals that showed no detectable thresholds. The hearing thresholds in the
two control groups were comparable, showing a normal hearing, whereas in the
KO animals an age-dependent hearing loss was evident. The age group I animals
responded with high thresholds to tone bursts, but displayed normal responses to
click stimuli. Older KO mice on the other hand (group II and III), hardly responded
to tone burst sounds and clicks. The results presented so far demonstrate a hearing
impairment in the Pwi KO, which becomes profound in adult animals, with ABRs
being hardly (group II, Figure 3.3 A, middle graph) or not at all (group III, Figure
3.3 A, right graph) elicited by tone bursts or clicks.
Additionally, distortion product otoacoustic emissions (DPOAE) were recorded
mostly in animals from age group II. Here, the age group I was not tested, as in young
animals the ear canal was very narrow and the microphone could not be positioned
properly. Because of the small number of animals recorded for DPOAE, the con-
trol group includes data from both Pwiflx/flx VDCR- CGCT+ and Pwi+/+ VDCR+
CGCT+ genotypes. As the data suggest (Figure 3.4 B), KO animals behave simi-
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larly to the controls and produce normal DPOAEs, in response to increasing sound
intensities (20, 40, 60, 80 dB SPL). Taking together, this result and the presence of
a summating potential indicate the presence of functional sound amplification in the
cochlea and mechanotransduction by the OHCs in the KO mice, at least at young
age.
3.1.4 The morphology of the Pwi organ of Corti
Cre-mediated recombination and likely cell-specific excision of the Wrb gene in KO
mice and correct genotyping for VDCR-CGCT in all groups, were verified by the
expression of the EGFP reporter in IHCs. Characteristic examples of the 3 different
genotypes used in this study, are presented in Figure 3.5. The fluorescent signal in
the KO (Pwiflx/flx VDCR+ CGCT+) IHCs indicated the recombination of the Wrb
gene and served as guide during the cell physiology experiments. Organs of Corti
of all genotypes were found to be normal with no gross morphological changes in
light microscopy (Figure 3.5, lower panel). Green fluorescence was not only found in
IHCs, but often, also in OHCs (Figure 3.5, upper panel, middle image), indicating
that the Vglut3 promoter is also active in the OHCs. The fluorescent signal was
detected in ∼80% of the IHCs in both the apical and basal (not shown here) parts
of the organs of Corti of CRE+ EGFP+ mice.
3.1.5 The conditional Wrb construct is recombined only in the presence
of Cre recombinase
As an additional way to confirm the recombination of the conditionalWrb construct,
I checked all three selected pinball-wizard genotypes by means of RT-PCR. Since
the loxP sites presumably surround only exons 2–4 in the targeted construct, I could
design primers that would allow me to test the length of the transcript to determine
whether it was recombined or not. The first loxP should be inserted inside intron 1,
just upstream of exon 2, while the second loxP is located in intron 4. By designing
primers that would bind inside exon 1 (forward primer) and at the beginning of
exon 2 (reverse primer), I was expecting to see Wrb transcripts of equal length in
the Pwi+/+ VDCR+ CGCT+ and Pwiflx/flx VDCR- CGCT+ organs of Corti, but no
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Pwi+/+ CRE+ EGFP+ Pwiflx/flx CRE- EGFP+
Figure 3.5: Cre activity is indicated by green fluorescent IHCs. Representative images
(snapshots) of apical coils of organs of Corti at 40x and 600x magnification. Note green fluorescent
cells in CRE+ but not in CRE- organs of Corti, which represent activation of Cre-mediated re-
combination and consequent expression of EGFP. In organs of Corti, green fluorescence is mostly
observed in IHCs. Scale bar at 40x magnification: 0.2 mm, scale bar at 600x magnification: 10
μm.
Interestingly, as shown in Figure 3.6 A, this was not the case. If the first loxP is
indeed located inside intron 2, the exon 2 should be lost upon recombination in the
KO and the reverse primer should not be able to find a binding substrate. On the
contrary, primers designed to bind to exons 1 (forward) and 5 (reverse) indicated
that recombination in KO had taken place. These primers could generate a long
transcript when recombination did not occur and exons 2–4 were present (as is the
case for Pwi+/+ VDCR+ CGCT+ and Pwiflx/flx VDCR- CGCT+), but generate a
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Figure 3.6: Testing the recombination by RT-PCR. Amplification of the transcripts spanning
(A) exon 1 to 2 and (B) exon 1 to 5. (C) Amplification of parvalbumin as positive control.
For simplicity KO denotes Pwiflx/flx VDCR+ CGCT+, floxed WRB denotes Pwiflx/flx VDCR-
CGCT+/-, and non-floxed WRB denotes Pwi+/+ VDCR+ CGCT+ animals.
from C57Bl/6J mice were used as external control and a sample containing water
and no DNA was used to detect potential contamination. Primers against parval-
bumin, an abundant IHC cytosolic protein that binds Ca2+, were used as a positive
control reaction to test the quality of the samples (Figure 3.6 C). It should be noted
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that the PCR was performed on whole organs of Corti (4 from each genotype) and
not on single cells. Thus, in the case of the Pwiflx/flx VDCR+ CGCT+, IHCs that
were negative for Cre activity as well as other cell types, carrying the Wrb gene were
also included and generated a product for non-recombined transcript (Figure 3.6 B,
at the KO sample the faint band at ∼700 bp.)
3.1.6 Disruption of synaptic function in Pwiflx/flx VDCR+ CGCT+ and
Pwiflx/flx VDCR- CGCT+ IHCs
After the observation of a progressive hearing loss in KO animals, I was intrigued
to investigate the mechanism of deafness at the level of the IHCs. I chose perfo-
rated patch-clamp measurements of Ca2+ currents and membrane capacitance to
test the presynaptic function in apical IHCs of Pwiflx/flx VDCR+ CGCT+, Pwiflx/flx
VDCR- CGCT+, and Pwi+/+ VDCR+ CGCT+ mice at P14–P17 (age group I). The
Ca2+ currents in the IHCs of the 3 genotypes were similar in amplitude (Figure 3.7
A), indicating an intact Ca2+ signaling. Characteristic examples of Ca2+ current
kinetics and capacitance changes in response to a 100 ms depolarization duration
stimulus are shown in Figure 3.7 B and C, respectively. The process of exocytosis
can be monitored by membrane capacitance measurements. Membrane capacitance
reflects the surface area of the membrane and changes in membrane capacitance
are proportional to increases or decreases in cell’s surface area, due to exocytosis or
endocytosis, which often do not overlap in their timing and hence can be reported
separately by the same measurement over time. To evoke exocytosis, cells were
depolarized to the voltage where maximal currents were observed (Figure 3.7 A)
for various durations. The observed changes in membrane capacitance and calcium
charge are displayed in Figure 3.7 D. The results demonstrate a significant differ-
ence between exocytic responses in Pwiflx/flx VDCR+ CGCT+ and Pwi+/+ VDCR+
CGCT+ IHCs and unexpectedly showed perturbed exocytosis also in one of the
control genotypes, the Pwiflx/flx VDCR- CGCT+. From the graphs displaying ΔCm
as a function of the depolarization duration (Figure 3.7 D, upper graph), I could
extract information about the amplitude and kinetics of the release of the readily
releasable pool (RRP) and the sustained component of exocytosis for all genotypes.
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Figure 3.7: IHC synaptic function of the Pwi mouse line. (A) Current-voltage (I-V) relation-
ship in IHCs of all three genotypes in 2 mM extracellular [Ca2+]. (B) Representative Ca2+ currents
and (C) Cm changes in IHCs in response to 100 ms depolarizations. (D) Kinetics of exocytosis,
ΔCm, (top) and corresponding Ca
2+ current integrals, QCa2+ (bottom) at various depolarization
durations. (E) ΔCm plotted versus QCa
2+. All measurements were performed in IHCs from age
group I (P14-P17). n shows the number of cells recorded. Data points represent mean values
± s.e.m. All data were tested for normality with Jarque-Bera and Kolmogorov-Smirnov tests
and for equal variances. Unless otherwise stated, a Mann-Whitney-Wilcoxon test was employed
(non Gaussian distributions and unequal variances.)  and  denote the significant difference be-
tween Pwiflx/flx VDCR+ CGCT+ (violet) and Pwi+/+ VDCR+ CGCT+ (green), Pwi+/+ VDCR+
CGCT+ and Pwiflx/flx VDCR- CGCT+ (black), respectively.
Although, in general, the exocytic release of the Pwiflx/flx VDCR+ CGCT+ IHCs
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was reduced as compared to the control Pwi+/+ VDCR+ CGCT+ IHCs, this dif-
ference only became significant for the sustained release (p = 0.007 for 50 ms and
p = 0.002 for 100 ms). At shorter depolarization durations (5–20 ms), by prob-
ing the release of the RRP, no significant difference was detected. Interestingly, in
control Pwiflx/flx VDCR- CGCT+ IHCs, the Cm responses at almost all stimulus
durations were significantly decreased compared to the other control group, Pwi+/+
VDCR+ CGCT+ (p = 0.01 for 10 ms, p = 0.007 for 20 ms, p = 0.005 for 50 ms,
and p = 0.002 for 100 ms). Since calcium currents seemed to be reduced in Pwiflx/flx
VDCR- CGCT+ IHCs, membrane capacitance responses versus Ca2+ charge were
plotted (Figure 3.7 E), which demonstrate a match in the efficiency of exocytosis
in Pwiflx/flx VDCR+ CGCT+ and Pwiflx/flx VDCR- CGCT+ IHCs. Together, the
electrophysiological data report that the IHCs of the KO Pwi are able to establish a
normal RRP, but exhibit diminished sustained exocytosis, which likely affects hear-
ing. However, exocytosis was comparably reduced in IHCs of the control Pwiflx/flx
VDCR- CGCT+, which showed normal hearing as assayed by ABR, a discrepancy
that remains unsolved.
3.1.7 Slowed vesicle pool replenishment in IHCs of Pwiflx/flx VDCR+
CGCT+ mice
The data acquired from studying membrane capacitance were further used to calcu-
late different kinetic parameters of the exocytosis of the KO and control Pwi IHCs.
I fitted the mean exocytic ΔCm values (Figure 3.7 D, upper graph), as a function of
stimulus durations of every genotype using the sum of an exponential and a linear
function. By these means, I estimated the size of the RRP of each genotype by
dividing the amplitude of the exponential function by the synapse number per IHC
(see section 3.2.1, Table 2) and by the single vesicle capacitance (∼45 aF) (Neef
et al., 2007). Additionally, the slope of the linear function provided information
for the rate of the sustained exocytosis. Sustained exocytosis was calculated by
dividing the slope of the linear function by the synapse number and by the single
vesicle capacitance (as described in Pangršič et al., 2010) (Figure 3.8 Table 1). Inner
hair cells of the Pwiflx/flx VDCR+ CGCT+ and Pwi+/+ VDCR+ CGCT+ mice have
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Table 1: Quantification of exocytosis
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0.30.2 0.5 0.70.60.4
Figure 3.8: Synaptic vesicle replenishment of Pwiflx/flx VDCR+ CGCT+ IHCs is slowed
down. (A) Representative Ca2+ currents and (B) Cm changes in response to a pair of 20 ms
depolarizations, separated by 150 ms. (C) Mean ratios (± s.e.m) of Cm response of the second
depolarization (ΔCm2) over the first (ΔCm1) as a function of interstimulus intervals, 0.09 s, 0.15
s and 0.3 s. At 0.3 s interstimulus time interval the recovery of exocytosis in Pwiflx/flx VDCR+
CGCT+ IHCs was significantly reduced as compared to Pwi+/+ VDCR+ CGCT+ IHCs.  p =
0.03 (t-test, see details in the text). (D) Table 1: Quantification of exocytosis
The observed reduction in the sustained component of the release in Pwiflx/flx
VDCR+ CGCT+ IHCs prompted me to further investigate the RRP recovery from
depletion using a paired-pulse stimulation. Here, the first depolarizing stimulus
triggers exocytosis and depletes the pool of RRP vesicles. Waiting for various time
intervals (90, 150, 300 ms) is expected to allow partial or complete replenishment
of the pool, which gets depleted again during a second depolarizing pulse. De-
pending on the initial depletion of the pool of vesicles and the ability of the cell to
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replenish this pool during the interpulse interval, the cell’s replenishment rate can
be evaluated by the second stimulus. RRP recovery was assessed as the ratio of the
membrane capacitance difference after the second pulse (ΔCm2) to the capacitance
difference after the first pulse (ΔCm1) for the various inter-stimulus intervals. Ex-
amples of calcium currents and corresponding membrane capacitance changes during
a paired-pulse stimulation with a 150 ms interstimulus interval are represented in
Figure 3.8 A and B. The replenishment rates are shown in Figure 3.8 C. Significant
difference was observed between Pwiflx/flx VDCR+ CGCT+ and Pwi+/+ VDCR+
CGCT+ at 0.3 s (p = 0.03), which is consistent with the observation of the reduced
sustained component of release. Reductions in the paired-pulse ratios were observed
at other interstimulus intervals and for the Pwiflx/flx VDCR- CGCT+ genotype as
well, however the differences did not reach statistical significance. This might be
due to relatively high variability in these demanding experiments, where a proper
depletion of the RRP pool during the first pulse was not always achieved.
3.2 Synaptic morphology
3.2.1 Indication of a progressive reduction in the number of ribbon-
occupied synapses of Pwiflx/flx VDCR+ CGCT+ IHCs
To test if the perturbation of the WRB protein in any way affects the number of
ribbon synapses, I further performed histological examination and analysis of the
apical coils of organs of Corti for all the three genotypes in age groups I and II by
means of immunolabeling. Antibodies against Ribeye/CtBP2, a major structural
component of the ribbon, and against GluA subunits 2/3, the post-synaptic AMPA
receptors, were used to stain the afferent ribbon synapse. Intact ribbon synapses
were identified by the presence of closely juxtaposed Ribeye/CtBP2 and GluA2/3
fluorescent spots (Figure 3.9, CtBP2 in red and GluA2/3 in green). I quantified
the number of IHC ribbon synapses by counting the juxtaposed pre- and post-
synaptic fluorescent spots of CtBP2 and GluA2/3 in maximum projections (stacks)
of confocal sections, divided by the number of nuclei in each stack. The results
(Figure 3.9 Table 2) show that the number of ribbon synapses in all three genotypes
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at age group I are similar, whereas there is an indication of age-dependent reduction
in synapses of Pwiflx/flx VDCR+ CGCT+ IHCs.
3.2.2 Unusually large vesicles accumulate at the KO synapse
To gain more insight into the morphology of the IHC ribbon synapses, I, in collabo-
ration with Dr. Carolin Wichmann, investigated the ribbon synapse ultrastructure
by means of electron microscopy. For the preliminary data set, embeddings of 1
organ of Corti from Pwiflx/flx VDCR+ CGCT+ animal and 1 from Pwiflx/flx VDCR-
CGCT+ animal were performed at room temperature and sections of 70 nm were
taken from multiple IHCs. In all IHCs of the Pwiflx/flx VDCR+ CGCT+ animal
and in some IHCs of the Pwiflx/flx VDCR- CGCT+ control animal, unusually large
vesicle-like structures, with diameter > 55 nm, were observed around the ribbon or
in close proximity to the synapse (Figure 3.10 a-f and Figure 3.11 g). Such vesi-
cles often formed clusters (Figure 3.10 c, d, f). Most ribbons in Pwiflx/flx VDCR+
CGCT+ IHCs were intact whereas some of them appeared to be partially disrupted,
showing a non-uniform shape (Figure 3.10 c and Figure 3.11 g). However, even such
ribbons tethered synaptic vesicles, of which some were found close to the plasma
membrane and were likely docked. All ribbons were also attached to the plasma
membrane. Furthermore, tubular structures with ribosomes on them (Figure 3.10
d and also in e and f without ribosomes) were often observed parallel to the presy-
naptic plasma membrane at Pwiflx/flx VDCR+ CGCT+. Although the nature and
origin of these vesicles is puzzling, it is tempting to speculate that they might be
related to cellular efforts to compensate for a deficit of TA protein insertion into the
membrane.
Vesicles around the ribbons within 500 nm radius from the active zone were quan-
tified for their size. Inside this area, the diameter of the vesicles was measured and
they were then categorized into three groups: ribbon-associated vesicles, vesicles be-
tween the ribbon and the presynaptic membrane (presumably docked), and vesicles
in the rest area of the 500 nm. Ribbon-associated vesicles I considered those vesicles
that were found in immediate apposition of the ribbon, had a circular shape, and
had an average diameter of 35–45 nm. I found a significant difference (p = 0.01)
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Age Group I (P14 - P19)
Age Group II (P21 - P29)
Pwi CRE+ EGFP+ Pwi+/+ CRE+ EGFP+ Pwi CRE- EGFP+/-
10616 53No. of investigated IHCs
12.2 ± 2.07 10.2 ± 1.8No. of synapses/cell
13 ± 1.98.06 9.8 ± 0.3No. of CtBP2 spots/cell





140 119 93No. of investigated IHCs
12.12 ± 1.65 9.6 ± 0.88 11.13 ± 1.92No. of synapses/cell
12.64 ± 1.72 10.2 ± 0.96 12.3 ± 1.76No. of CtBP2 spots/cell












































Figure 3.9: Quantification of ribbon synapses. Representative example projections of con-
focal sections of IHCs (age group I) following immunolabeling of ribbons (anti-CtBP2, red) and
glutamate receptors (anti-GluA2/3, green). (A) Pwiflx/flx VDCR+ CGCT+, (B) Pwi+/+ VDCR+




in the number of “large vesicles” (with diameter > 55 nm) at the synapses of the
Pwiflx/flx VDCR+ CGCT+ (4.1 ± 0.8) compared to the Pwiflx/flx VDCR- CGCT+
control (1.4 ± 0.3) (Figure 3.12 A) and almost a two-fold reduction (p = 0.001) in
Pwiflx/flx CRE+ EGFP+   (P21)






Figure 3.10: Ultrastructural analysis of the Pwi ribbon synapse. Transmission electron
micrographs of IHC ribbon synapses in Pwiflx/flx VDCR+ CGCT+ animal P21 (a-d) and P14
(e-f). Scale bars are 200 nm.
the number of ribbon-associated vesicles (diameter ∼45 nm) in Pwiflx/flx VDCR+
CGCT+ IHCs (5.5 ± 0.2 and Pwiflx/flx VDCR- CGCT+: 9.7 ± 0.6) (Figure 3.12
B). The number of the ribbon-associated vesicles in the Pwiflx/flx VDCR- CGCT+
was similar to the average number found at the IHC ribbon synapses of the WT
C57Bl/6J mice (Dr. Carolin Wichmann personal communication).
In summary, synapse number was normal in Pwi KO IHCs at the age group
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Figure 3.11: Ultrastructural analysis of the Pwi ribbon synapse (controls). Transmission
electron micrographs of IHC ribbon synapses in Pwiflx/flx VDCR- CGCT+ animal P21 (g-i) and
one example C57Bl/6J P14 (j). Scale bars are 200 nm.
I. Analysis of the ribbon synapse morphology revealed unusual vesicle and ribbon
patterns. IHCs of Pwiflx/flx VDCR- CGCT+ mice showed impaired exocytosis and
some morphological abnormalities of IHC ribbon synapses.
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Pwiflx/flx CRE+ EGFP+ Pwiflx/flx CRE- EGFP+/- Pwiflx/flx CRE+ EGFP+ Pwiflx/flx CRE- EGFP+/-
o o
Figure 3.12: Quantification of ultrastructural analysis of the IHC ribbon synapses. (A)
Average number of SV with diameter > 55 nm in the two genotypes studied (B) Average number
of ribbon-associated SV in the two genotypes. Two-tailed paired T-test was applied. ◦ denotes the
significant difference between Pwiflx/flx VDCR+ CGCT+ (violet) and Pwiflx/flx VDCR- CGCT+
(black). Data are represented as mean ± s.e.m.
3.3 Effect of the Wrb deletion on the molecular composition
of the IHC ribbon synapse
Where does WRB localize to in the IHC? Does it act as a receptor of tail-anchored
(TA) proteins and/or does it participate more actively at the synaptic site? How
does Wrb deletion affect the expression levels and trafficking of the TA protein
otoferlin in IHCs? These questions are the key for deciphering the role of WRB in
the IHCs.
3.3.1 Reduced otoferlin protein levels
I first addressed the question whether the protein levels of otoferlin are affected
in the IHCs of the Pwi KO. Both, expression levels and localization pattern of
otoferlin were studied by semi-quantitative confocal microscopy of immunolabeled
IHCs. Apical coils of organs of Corti of all the 3 genotypes and age groups were
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immunolabeled with antibodies against the N-terminus of otoferlin and VGLUT3
and confocal sections were acquired using the same settings (Figure 3.14).
EGFP otoferlin
mergevglut3
Figure 3.13: Expression pattern of otoferlin distribution in the first cochlear turn.
Characteristic examples of images from single confocal sections of an apical cochlear turn of a
Pwiflx/flx VDCR+ CGCT+ animal. Expression patterns of: endogenous EGFP, as a result of the
Cre activity, otoferlin and VGLUT3 after immunolabeling with specific antibodies.
A custom macro, written by Dr. Tina Pangršič was used to quantify the fluores-
cence signal and investigate the subcellular distribution of otoferlin and VGLUT3.
The results show a tendency toward lower otoferlin fluorescence in the IHCs of the
Pwiflx/flx VDCR+ CGCT+ mice at all ages, both in apical (Figure 3.15 A) as well
as in basal parts of the cells (Figure 3.15 B); however, more data are required to
definitely confirm or reject this observation. Interestingly, the fluorescence in the
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Figure 3.14: Expression pattern of otoferlin distribution in apical cochlear IHCs. Max-
imum projections of confocal Z sections of apical IHCs of the three different genotypes and age
groups, following immunolabeling for otoferlin (in red) and for VGLUT3 (in green), processed and
imaged under the same conditions. Scale bar is 10 μm.
control Pwiflx/flx VDCR- CGCT+ IHCs seems to be stronger as compared to the
control Pwi+/+ VDCR+ CGCT+ IHCs.
3.3.2 Disruption of the protein WRB changes the distribution of the
TRC40 interaction partner
In mammalian cells, Wrb has been proposed to act as a receptor of TA proteins
(Vilardi et al., 2011). The pathway mediating insertion of TA proteins to the ER
membrane demands a cytosolic factor, TRC40, that can deliver the newly synthe-
sized polypeptide to the ER receptor. The interaction of TRC40 with WRB is an
important step for the insertion of the protein to the ER (Yamamoto and Sakisaka,
2012). Upon deletion of Wrb, the TRC40 protein membrane insertion pathway is
likely disturbed. I tested for TRC40 expression in IHCs by immunohistochemistry
in Wrb KO IHCs, using a TRC40 antibody, generated and kindly provided by Dr.
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Figure 3.15: Semi-quantitative evaluation of otoferlin protein levels. Average fluorescence
intensity of otoferlin (upper graph) and VGLUT3 (lower graph) for the (A) apical part and (B)
basal part of IHCs of all three genotypes and age groups. In the Y axis, the fluorescence values
are presented in arbitrary units (a.u.).
sion levels were examined in apical IHCs of two Pwiflx/flx VDCR- CGCT+, and two
Pwiflx/flx VDCR+ CGCT+ animals. Otoferlin antibody was used as an IHC marker.
The data indicate that TRC40 is indeed expressed in mouse IHCs and mostly
localizes to the cytoplasm of the basal part. On the contrary, TRC40 was almost
absent from the basal part of IHCs in the Pwiflx/flx VDCR+ CGCT+ IHCs, in agree-
ment with the initial hypothesis, while a faint signal remained in the very apical
part of the cells, close to the hair bundles (Figure 3.16).
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Figure 3.16: Reduced expression of TRC40. Maximum projections of otoferlin and TRC40
staining in apical IHCs. Scale bar: 10 μm .
3.4 Silencing of otoferlin
Previous data in otoferlin mutant mouse model suggested that the perturbation of
otoferlin might affect the synaptic function of IHCs in a dose-dependent manner
(Pangršič et al., 2010). Our results in the pinball-wizard KO IHCs, demonstrating
a reduction in sustained component of IHC exocytosis together with a reduction in
otoferlin levels, also support this notion. Therefore, I aimed at testing this hypoth-
esis by selectively reducing the expression levels of otoferlin, without concomitant
deletion of another protein (like WRB) or putative changes in the structure of the
otoferlin protein (like discussed for the pachanga mutants). To this aim, I proposed
to use two approaches: first, a silencing of the expression of otoferlin, and second,
to investigate synaptic function in otoferlin heterozygous animals, which also show
partially reduced levels of otoferlin in IHCs (Pangršič et al., 2010).
A knock-down system that would allow the disruption of expression of the vari-
ous proteins in a relatively easy and quick way, without the generation of transgenic
mouse lines, could become an exceptionally useful tool. My purpose was there-
fore to establish an IHC-targeted silencing system, which I planned to first use to






















Figure 3.17: Construction of the silencing vectors. (A) Illustration of the map of the original
backbone vector, pEGFP-C1, which was used for insertion of the miRNA-like silencing oligomers.
The endonuclease restriction sites XhoI and HindIII indicate the position of the insertion of the
microtemplate cassette, as described in the chapter Materials and Methods. (B) The mammalian
vector in which the individual miRNA-like silencing molecules were cloned downstream of EGFP.
3.4.1 In vitro silencing
Initially, I screened 8 different (4 silencing and 4 scramble) miRNA vectors for their
transfection efficiency and for any possible toxicity in HEK 293T mammalian cells.
Very high transfection levels (∼90%) were indicated by the EGFP fluorescent pos-
itive cells and no cell toxicity was observed in DAPI staining (not shown). Next,
in order to assess the silencing capability of the individual miRNAs, I performed
double-plasmid transfections in HEK cells and quantified the protein levels by west-
ern blot analysis. Full-length mouse otoferlin cDNA, expressed by a pEGFP-N1
vector (produced by Dr. Ellen Reisinger), was transfected together with one or two
miRNA vectors into HEK cells. Multiple combinations of plasmid concentrations
were tested, using Lipofectamine 2000 and calcium phosphate transfection proto-
cols. In the quantification presented in Figure 3.18, 3 μg of DNA were used in single
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Figure 3.18: In vitro silencing - Protein level quantification. Western blot analysis for otofer-
lin in HEK 293T cells: untransfected cells, transfected with otoferlin vector, double transfection
with otoferlin vector and a gene-empty vector, otoferlin vector and pEGFP-C1scramble1, otofer-
lin vector and pEGFP-C1scramble2, otoferlin vector and pEGFP-C1miRNA1, otoferlin vector
and pEGFP-C1miRNA2, and otoferlin vector and pEGFP-C1miRNA1 and pEGFP-C1miRNA2.
Protein levels as measured from the intensity of the otoferlin bands, normalized to the sample
transfected with otoferlin alone, indicating the silencing effect.
transfections and 6μg of DNA in double transfections. Only 2 silencing sequences
proved to efficiently knock-down otoferlin (Figure 3.18 blot). The two scramble
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sequences induced a small reduction in the levels of otoferlin, when compared to
the sample where only otoferlin was overexpressed. Result of the transfection with
otoferlin and the gene-empty vector shows protein levels similar to the samples
transfected with the scramble, leading to the conclusion that the reduction is not
an effect of the scramble sequence but probably rather due to a reduced uptake
of plasmid in multiple-plasmid transfections, resulting in reduced expression levels
when co-transfecting with any kind of plasmid. Still, the knock-down of otoferlin
caused by the silencing sequence was remarkable no matter what negative control it
was compared to (Figure 3.18, graph).
Having successfully designed and selected functional silencing molecules against
otoferlin, I proceeded with viral silencing. For the successful delivery of the most
prominent miRNA silencing molecules into mouse IHCs, I chose a viral vector strat-
egy, reported to be suitable for the mouse inner ear and causing no immunogenic-
ity (Reisinger et al., 2011; Reuter, 2011). The entire DNA cassette, expressing the
EGFP gene and the miRNA, was inserted into an adeno-associated viral (AAV) vec-
tor of serotypes 1 and 2 (chimeric capsid). AAV1/2 has previously been shown to
effectively transduce IHCs. The expression was driven by the human CMV enhancer-
chicken beta actin promoter (Figure 3.20 A). The first viral preparations were first
tested for their transduction efficiency in HEK cells. Because of the very low titers
(AAV-miRNA1: 0.8 x 108 tu/μl, AAV-miRNA2: 108 tu/μl, AAV-scramble: 1.2 x
108 tu/μl, AAV-scramble2: 108 tu/μl, ), the expectations for transduction success
were rather low. Consequently, the transfection efficiency, as monitored by EGFP
fluorescence, was relatively low. Labeling of the cells with DAPI to visualize nuclei
did not show any obvious toxicity caused by the viruses (Figure 3.19).
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Figure 3.19: In vitro silencing. Confocal images of HEK 293T cells stained with anti-GFP
antibody (green) and DAPI (blue) after transfection of the first viral preparation. Examples of
transfected cells with pEGFP-C1miRNA2 vector and pEGFP-C1scramble2 vectors. Scale bars are
0.2 mm.
3.4.2 In vivo silencing
Transuterine otocyst injections (Reuter, 2011) were performed in order to deliver the
virus into the developing otocyst in E11.5 mice. Initially, the first viral preparation,
also tested in vitro, were injected. Injections were performed always in the left
developing otocyst of each mouse, allowing the use of the organ of Corti of the right
side as a negative control. The organs of Corti from the right and left ears of all
surviving animals were analyzed at P20 for positive transduction by immunolabeling
with an antibody against otoferlin and a GFP antibody conjugated conjugated to
Alexa 488. The transduction efficiency in these experiments turned out to be very
low (< 5% transfection rate, Figure 3.20 B). The main reason for this were possibly
the low titers of the viruses used here. All right organs of Corti were negative for
EGFP (data not shown). A further attempt was made to repeat the injections
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with a second viral preparation. The higher titers of this batch (AAV-miRNA1:
4x108 tu/μl, AAV-scramble1: 4x108 tu/μl) proved to be highly advantageous, as
the transduction efficiency has drastically increased (∼40%). Examples of IHCs







miRNA 2 scramble 2
Figure 3.20: Silencing of otoferlin in mouse IHC - First viral preparation. (A) Illustration
of the viral sequence after insertion of the “silencing” cassette. (B) Examples of immunolabeled
apical left (injected) cochlear turns of P15 CDI animals, injected with the first viral preparation
(miRNA1, miRNA2, scramble2). Scale bars are 10 μm.
are shown in Figures 3.21 and Figures 3.22. Still, the transduction rates were not
consistent along the entire length of the organ of Corti and there were variations
in the expression levels of EGFP. Nevertheless, in some cases, as shown in the left
most panel in Figure 3.21, silencing with miRNA1 almost entirely abolished otoferlin
expression. The negative control (non-injected ear, Figure 3.21, right most panel),
did not appear to show any changes in the levels of otoferlin. Unfortunately, the
results of the injection of the negative scramble sequence were not conclusive. The
fluorescence intensity of the otoferlin staining is low in both the right and the left
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Figure 3.21: Silencing of otoferlin in mouse IHC - Second viral preparation (miRNA1).
Examples of immunolabeled apical left (injected) and right (non-injected) cochlear turns of P15
CDI animals, injected with the second viral preparation (miRNA1). Scale bars are 10 μm.
ear, coming mostly from the presynaptic membrane of the IHCs and suggesting
low otoferlin levels. Still, similar fluorescence intensities in both the injected and
non-injected ear, suggest that the expression of otoferlin was not impaired, but that
the immunohistochemistry did not work properly. Additionally, a similar expression
pattern for the protein was observed between scramble1 transduced (EGFP positive)
and non-transduced (EGFP negative) IHCs of the injected ears.
In summary, the results suggest that miRNA-mediated silencing of otoferlin in the
mouse IHCs of the organ of Corti is feasable, however only when viruses with high
titers are used. The strategy followed, seems to yield efficient knock-down, but still
needs to be optimized using better negative controls.
3.4.3 Synaptic transmission of mouse otoferlin heterozygous animals
As a second approach, to test whether there is a relationship between otoferlin
protein levels and synaptic function, I investigated the presynaptic function of
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Figure 3.22: Silencing of otoferlin in mouse IHCs - Second viral preparation (scramble1).
Examples of immunolabeled apical left (injected) and right (non-injected) cochlear turns of P15
CDI animals, injected with the second viral preparation (scramble1). Scale bars are 10 μm.
IHCs of the otoferlin heterozygous (Otof+/-) animals and littermate controls, using
perforated patch-clamp recordings of depolarization-evoked membrane capacitance
changes. The results indicate that the ribbon synapse seems to operate normally
(Figure 3.23) when otoferlin protein levels are at 70% of the wild-type levels, with no
obvious disturbance in the fast or slow component of exocytosis. If indeed the IHC
synaptic function depends on the expressed level of otoferlin, one needs to reduce
the expression of otoferlin even further. Perhaps, there is a threshold below which
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Figure 3.23: Exocytic performance of Otof+/- IHCs. (A) Kinetics of exocytosis:
Depolarization-evoked membrane capacitance increments (ΔCm top) and corresponding Ca
2+ cur-
rent integrals (bottom) are plotted versus the duration of depolarization for Otof+/+ (black, n=8)
and Otof+/- (yellow, n=12) IHCs. (B) Current-voltage (I-V) relationship of IHCs bathed in 2 mM
[Ca2+]. (C) ΔCm plotted versus QCa
2+. All measurements were performed in IHCs of P14-P17
animals. n shows the number of the recorded cells. Data points represent mean values ± s.e.m.




The inner hair cell (IHC) synapse encodes sound and is the first synapse in the
auditory pathway. Ongoing research aims to understand the molecular mechanisms
underlying synaptic sound encoding. However many of the constituents of the in-
volved molecular machinery remain unknown. Mice either lacking (KO) otoferlin
(Roux et al., 2006) or with ∼30% of the physiological protein levels (pachanga mu-
tant) (Pangršič et al., 2010) show profound deafness as a consequence of a defect in
Ca2+-dependent exocytosis. These findings highlighted the importance of otoferlin
for the function of in IHC ribbon synapses and led to the hypothesis that it may
function as the main Ca2+ sensor (Roux et al., 2006) and/or priming factor at the
IHC ribbon synapse (Pangri et al., 2012).
Otoferlin binds to membranes via its C-terminus single transmembrane domain
and more specifically, has been found associated with synaptic vesicle membranes
and plasma membrane (Roux et al., 2006). The prediction that otoferlin is a
tail-anchored (TA) protein (Kalbfleisch et al., 2007), suggests that it may use the
TRC40/WRB membrane insertion pathway; nevertheless, to date, there is no bio-
chemical evidence to support this conjecture. The gene that encodes tryptophan-
rich basic protein (WRB) was originally identified in humans to be linked with a
gene for congenital heart disease (CHD) and was proposed to be involved in the
pathogenesis of CHD (Egeo et al., 1998). Nevertheless, this hypothesis has not been
confirmed and it was only very recently that a role as a TA protein receptor has been
attributed to WRB (Vilardi et al., 2011). Additional novel findings demonstrated
that mutation of the zebrafish wrb gene (pwi mutant) leads to hearing, visual, and
balance deficits (Lin et al., unpublished). However, how exactly WRB, which is
a non-synaptic protein, is implicated in hearing, remained to be determined. One
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hypothesis is that the interaction of WRB with otoferlin regulates the membrane
insertion of the latter; thus, the absence of WRB influences the function of otoferlin
and consequently the synaptic function of IHCs.
This study addressed the relatively novel protein WRB and its function in the
mouse auditory system. I used Cre homologous recombination for the targeted
deletion of the Wrb gene only in those tissues that express glutamate transporter-3
(VGLUT3). Besides IHCs, where only isoform 3 of the transporter family (VGLUT)
is expressed (Ruel et al., 2008; Seal et al., 2008), VGLUT3 expression is scattered
throughout the glutamatergic synapses in the brain, as well as in cholinergic, sero-
toninergic, and GABAergic synapses (Fremeau et al., 2001). Additionally, VGLUT3
is expressed in the retina, heart, liver, and kidney (Munguba et al., 2011).
4.1 Seizures and lethality in the Pwi KO mice
The first obvious phenotypic characteristic of the Pwi KO mice (Pwiflx/flx VDCR+
CGCT+), which was also observed in the zebrafish pwi mutant (Lin et al., submit-
ted), was a circling behavior that was accompanied by a tendency of the mice to
lean toward the side. This finding is strongly suggestive of a vestibular disorder that
will be investigated in future work. A more dramatic phenotype was the occurence
of epileptic seizure-like episodes. In contrast to the seizures described in VGLUT3
KO mice (Seal et al., 2008), Pwiflx/flx VDCR+ CGCT+ mice completely lost motor
control and suffered for several minutes during these attacks. There seems to be a
neurological disorder underlying this behavior as a consequence of the deletion of
the protein in certain brain areas. Usually, seizures occur from a defect in inhibitory
neurons, or an imbalance of excitatory-inhibitory input in a part of the brain that
leads to over-excitability (Dichter and Ayala, 1987). That is consistent with the idea
of a defect related to the excision of the Wrb gene in neurons expressing VGLUT3.
In the future, it will be interesting to thoroughly investigate the consequences of the
absence of WRB in the mouse brain. One possible hypothesis is that the absence
of WRB might perturb the biogenesis of proteins like synaptobrevin 2, shown to
be a TA protein (Kutay et al., 1995) and/or syntaxins, predicted to be TA pro-
teins (Kalbfleisch et al., 2007). If synaptobrevin cannot be inserted properly to the
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ER membrane, it will never get loaded into the synaptic vesicle membrane, which
in turn would cause a defect in synaptic exocytosis. Taken that in Pwi KO the
Wrb gene gets deleted also in the heart, a neurological disorder in combination
with a heart failure problem might result in the rapid deterioration of the condition
of Pwiflx/flx VDCR+ CGCT+ mice. If this is true, it may indicate the functional
importance of the WRB pathway for many TA proteins, which are expressed in
the central nervous system and heart. To define the neurological characteristics of
Pwiflx/flx VDCR+ CGCT+ mice more accurately, future work necessitates the use of
electroencephalography to analyze the epileptic seizures.
4.2 Down-regulation of TRC40 in the absence of WRB
The consequences of the deletion of the Wrb gene in the Pwi KO mice would be bet-
ter understood if more light could be shed on the posttranslational protein insertion
pathway WRB participates in. Eventually, the identification of interaction partners
of WRB within this pathway could help understanding the role of this protein in
the various tissues. So far, literature suggests that TRC40 is the protein targeting
factor in this pathway (Stefanovic and Hegde, 2007) and interacts with WRB for in-
sertion of tail-anchored (TA) protein into the endoplasmic reticuclum (Vilardi et al.,
2011; Yamamoto and Sakisaka, 2012). Interestingly enough, elimination of any of
these two proteins in independent mouse models leads to lethality either at embry-
onic stage (Mukhopadhyay et al., 2006) or within two months of life (this study).
Moreover, an attempt to generate a global Wrb KO mouse model failed, because of
early embryonic lethality (David Corey, personal communication). In the current
study, the expression of TRC40 in IHCs was highly reduced in Pwiflx/flx VDCR+
CGCT+ compared to Pwiflx/flx VDCR- CGCT+. In order to gain more insight into
the role of WRB and TRC40, it is crucial to investigate their localization and po-
tential co-localization in IHCs, brain, and other tissue. So far unfortunately, none
of the available antibodies for WRB, neither commercial nor custom-made, seem to
specifically bind to WRB, at least not in the cochlear tissue.
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4.3 Progressive hearing loss in Pwi KO mice is probably
attributed to the dysfunction of IHCs
The observed progressive impairment in hearing function upon deletion of Wrb in
auditory cells likely results from defects of TA protein trafficking in hair cells. Hear-
ing loss in Pwi KO mice was assessed by studying synaptic neurotransmission at
P15 IHCs. The analysis indicated that the IHC synapses of Pwiflx/flx CRE+ EGFP+
mice are able to maintain an intact readily releasable pool (RRP) of vesicles, and
promote exocytosis upon Ca2+ influx. The significant decrease in the sustained rate
demonstrated that the replenishment process at the ribbon was impaired, which
may be responsible for the observed hearing loss. Severely slowed vesicle replenish-
ment at the IHC ribbon synapses has also been reported in the otoferlin pachanga
mutant, suggesting that it leads to auditory fatigue and deafness (Pangršič et al.,
2010). However, the same assumption cannot be claimed for the control Pwiflx/flx
CRE- EGFP+ mice, which showed a significant decrease in both fast and sustained
exocytosis, but no hearing deficit. The summating potential, which is thought pri-
marily to indicate the receptor potential of IHCs and outer hair cells (OHCs), was
present in the first two age groups studied (groups I and II), while it disappeared ap-
proximately at the age when lethality was observed (group III). On the other hand,
distortion product oto-acoustic emissions (DPOAE) could be detected in group II.
If it can be assumed that the summating potential reflects mostly the sensitivity of
IHCs, while DPOAEs report the OHC mechanotransduction activity, then a plausi-
ble scenario could be that the hearing deficit is at least partially caused by disruption
of mechanotransduction in IHCs. Moreover, a deficit in the transduction machinery
has been observed in the zebrafish pwi mutant, suggesting that Wrb in zebrafish
modulates the transduction apparatus (Lin et al., unpublished). Therefore, is quite
possible that an IHC mechanotransduction defect is also responsible for the observed
deafness in Pwi KO mice. To test better this hypothesis a closer investigation of
the properties of MET currents and DPOAE recordings at a later age will further
help to characterize the hearing phenotype.
From the earliest developmental stage studied, Pwi KO mice had much reduced
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wave I and wave III amplitudes compared to the controls. Wave I is thought to
derive from the synchronous spiking activity of the auditory nerve, while wave III is
thought to derive from the activity of the neurons in the superior olivary complex
in the brainstem (Melcher et al., 1996). The expression of VGLUT3 in the lateral
superior olive (Gillespie et al., 2005) is necessary for glutamate release in this area
(Noh et al., 2010). Again, it could be assumed that the targeted deletion of the Wrb
gene may create several protein imbalances that lead to the dysfunction of sound
processing in this auditory neuronal center. Collectively, hearing loss in the pinball-
wizard KO could be attributed to a defect in the spiral ganglion neurons, which form
the auditory nerve, and possibly also to the superior olivary complex. However, it is
unclear why this defect appears to progress in a developmental-dependent manner.
4.3.1 Recombination in the Wrb gene
The striking finding of perturbed synaptic transmission in Pwiflx/flx VDCR- CGCT+
mice is difficult to be explained. Apart from synaptic function, no other deficit was
observed that could be compared with Pwiflx/flx VDCR+ CGCT+ mice. To exclude
the possibility of the Wrb gene disruption during the generation of the targeted
construct, organs of Corti from P25 Pwiflx/flx VDCR+ CGCT+, Pwiflx/flx VDCR-
CGCT+, and Pwi+/+ VDCR+ CGCT+ animals were analyzed for the length of the
Wrb transcript after recombination. Successful recombination in the presence of
Cre deleted the exons 2–4 located between the loxP sites, only in Pwiflx/flx VDCR+
CGCT+ mice, while in Pwiflx/flx VDCR- CGCT+, the transcript length is identical
to the other control (Pwi+/+ VDCR+ CGCT+). Nevertheless, amplifying the region
between exons 1 and 2 was not expected to generate a product for Pwiflx/flx VDCR+
CGCT+, assuming that the primer for exon 2 cannot find a binding site inside the
recombined Wrb. Interestingly, this was not the case, indicating that part of exon
2 was probably still present in Pwiflx/flx VDCR+ CGCT+. These results lead to
two important conclusions. First, they demonstrate that the Wrb gene cannot get
deleted in the absence of Cre, as is the case in the Pwiflx/flx VDCR- CGCT+ animals,
so the potential undesired excision in these animals can be excluded. Second, the
results obtained from the primers targeting the region between exon 1 and 2 propose
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that the first loxP site might be inserted in a different position than the one suggested
by the manufacturer of the pinball-wizard conditional mouse line, possibly inside
exon2. If this is true then certain structural changes in the gene might affect the
resulting mRNA and finally the protein itself. Nevertheless, it should be noted that
since the PCR was performed on whole organs of Corti, the observed transcript,
most probably appears from those cells where recombination has not happened.
4.3.2 A defect of the ultrastructure of IHC ribbon synapse
In the synapse quantification analysis, no significant difference between any three
genotypes in age group I was observed. The number of KO ribbon synapses was
found to be in the range of that observed in wild-type mice (Meyer et al., 2009).
On the contrary, a small decrease was found in age group II, but this finding is not
yet conclusive and needs to be investigated further. If there is indeed a progressive
decline in the number of synapses at the IHCs of the Pwiflx/flx VDCR+ CGCT+
mice, this could lead to a progressive loss of spiral ganglion neurons, which might
explain the progressive hearing dysfunction. In support of this statement, it should
be mentioned that at the early age (group I), when cell physiology recordings were
performed, the ABR recordings in the Pwiflx/flx VDCR+ CGCT+ mice did not indi-
cate a complete hearing impairment.
To gain more insight into the mechanism of the slowed replenishment at the pinball-
wizard KO IHC ribbon synapse, electron microscopy (EM) was used to examine
the structure and formation of ribbon synapses. In the two genotypes studied, the
average number of ribbon-associated synaptic vesicles per synapse section was sig-
nificantly reduced in IHCs of Pwiflx/flx VDCR+ CGCT+ mice compared to Pwiflx/flx
VDCR- CGCT+ mice, which interestingly, had almost exactly the same number of
vesicles as the stimulated synapse of the pachanga mutant (Pangršič et al., 2010).
However, ribbon formation did not appear to be significantly impaired and can there-
fore probably not explain the reduced number of tethered vesicles. It is likely that
the probability that vesicles could accumulate around the ribbon was diminished
because of a significant increase in unusually large vesicles, which formed clusters
either in the proximity of the ribbon or in an 500 nm area around it. The ex-
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act nature of such structures is unknown and should be further investigated with
immuno-EM using endosomal markers, e.g., Rab5 and EEA1, or synaptic vesicle
markers, e.g., synaptobrevin 2 and otoferlin.
The identification of a synaptic link between the absence of WRB and the ob-
served hearing defects was intriguing, and my working hypothesis was that the dis-
ruption of the membrane insertion pathway could influence the trafficking of otoferlin
from the cytoplasmic sites of translation to the ER membranes. If otoferlin cannot
get incorporated to the ER membrane, it will not be folded correctly and will not
be present on the vesicles. Unfortunately, I was unable to investigate this hypoth-
esis during the course of this study, which will require future in vitro biochemical
experiments. However, in order to gain some insight into this hypothesis, I evalu-
ated the protein levels of otoferlin using a semi-quantitative approach. I observed
a tendency for Pwiflx/flx VDCR+ CGCT+ mice to express less otoferlin at the apex
and base of IHCs than control Pwi+/+ VDCR+ CGCT+ IHCs, whereas for Pwiflx/flx
VDCR- CGCT+ IHCs, the opposite trend was observed. In addition, a distribution
pattern analysis indicated a mostly diffuse distribution of otoferlin throughout the
cytoplasm. However, these results are preliminary and no firm conclusions can be
made at this point. A more systematic analysis should be conducted in the future.
For the absolute quantification of protein levels, western blot analysis of the whole
organs of Corti would be beneficial. Unfortunately, none of the efforts yielded any
result, mainly because of the small size of the tissue and the requirement of relatively
large amounts of material for successful western blot analysis.
4.4 Hypotheses on the function of WRB in IHCs
The deletion of the Wrb from IHCs apparently creates an exocytic deficit, which is
manifested in in Pwiflx/flx CRE+ EGFP+ mice as a reduced replenishment rate and
large vesicle clusters. The proposed hypothesis is that in the absence of WRB, traf-
ficking of certain synaptic protein components or even ribbon scaffold proteins gets
disrupted. Thus, the observed phenotype could be attributed to the dysfunction of
several proteins at the synapse. If synaptic vesicles cannot carry all required pro-
teins, e.g., otoferlin, or even bud from the ER, they will never have the opportunity
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to reach the synapse and become fusion-competent, but instead they might form
clusters. On the other hand, a compensatory mechanism might still enable the par-
tial function of the membrane insertion pathway. It was recently shown (Yamamoto
and Sakisaka, 2012) in mammalian cell-based in vitro assays, that calcium-signaling
modulating cyclophilin ligand (CAML) is part of the receptor complex of TA pro-
teins in the ER. Both CAML and WRB are required for TRC40/TA protein binding
to the ER, but they also compete for this interaction. Therefore, it is tempting to
suggest that in the absence of WRB, CAML takes over the insertion of proteins into
the ER; however, it is unable to rescue the process completely. The tubular struc-
tures that were observed close to the presynaptic membrane of the Pwiflx/flx CRE+
EGFP+ IHCs were considered to be ER membranes with ribosomes. Although this
notion needs to be further confirmed, the presence of the ER so close to the ribbon
synapse might also serve as a compensatory mechanism to the high demands for
protein trafficking. Again, the identification of the distribution pattern of WRB
inside IHCs is crucial for confirming its role as a TA protein receptor and also to
indicate its interaction partners.
Considering these findings together, the Pwi KO mice share many similarities
with the otoferlin pachanga mutant. In both, the fast component of synaptic vesicle
release is intact, but vesicle replenishment is compromised, indicated by decreased
sustained rates of exocytosis. While in pachanga mutant sustained rate of release was
decreased by ∼70%, in pinball-wizard KO it was reduced by ∼50%. In pachanga mu-
tant one single point mutation of otoferlin caused the inability of the IHC synapse to
refill with synaptic vesicles and maintain neurotransmission, while in pinball-wizard
KO, deletion of WRB may disrupt the membrane protein insertion pathway and
influence the biogenesis of multiple other proteins with a role at the synapse. If a
progressive reduction in the number of synapses can be shown, it would suggest the
downstream degeneration of spiral ganglion neurons and provide a second possible
explanation of the absence of wave I in ABR recordings. Together with or inde-
pendent of an impaired transduction machinery in OHCs it would suggest the early
disruption of the auditory pathway function.
The choice of the Vglut3 -CRE reporter line VDCR-CGCT was based on the
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desire of IHC-specific Wrb deletion. Apparently, targeted excision of the gene did
not occurr solely in the cochlea, given the broad tissue expression of VGLUT3.
Although the physiological findings are of great experimental interest and reveal a
major role of WRB in multiple tissues, it is not easy to isolate one particular defect,
excluding the implication of others. Alternatively, another IHC-specific Cre mouse
line could be used in order to study the function of WRB exclusively in the auditory
pathway, which however, is currently not available yet.
4.5 Silencing otoferlin in the mammalian inner ear
A parallel project that was conducted, aimed to establish a strategy for miRNA-
mediated gene silencing. The motivation was guided by the idea, initially suggested
by Pangršič et al., (2010), that perturbations in the protein levels of otoferlin, re-
sult in variations of the synaptic performance at the IHC ribbon synapse. It was
thus tempting, to try to manipulate the protein levels and investigate the pheno-
typic variations. The choice of miRNA silencing cassettes and not of shRNA or
siRNA, was based on two factors. First, I needed to achieve stable gene silencing
(Brummelkamp et al., 2002; Paddison et al., 2002), which could not be the case
with siRNA. Second, I wanted that the silencing molecule would mimic as much
as possible the endogenous mammalian RNA interference (RNAi) pathway, in or-
der to minimize the chances of cellular toxicity, due to off-target effects. The use
of shRNA molecules was avoided, because they require special promoters (Liu and
Berkhout, 2011) as they are transcribed by RNA polymerase III, whereas miRNA is
transcribed as any other gene by RNA polymerase II. Therefore, it was advantageous
to use miRNA and consequently only one promoter to drive simultaneously the ex-
pression of an miRNA silencing molecule and of the reporter gene. The successful in
vitro experiments, confirmed the designed strategy and indicated those miRNA si-
lencing molecules that significantly could reduce the levels of otoferlin as compared
to controls. Taking full advantage of the recently established method of embry-
onic trans-uterine otocyst injection (Reuter, 2011), miRNA silencing cassettes were
futher delivered by adeno-associated viral (AAV) vectors to the developing otocyst
of 11.5 days embryos. The chimeric AAV1/2 serotype has been shown to effectively
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transduce mouse IHCs (Reuter, 2011), while other viruses, like Semliki, Forest Virus,
Lentivirus and several AAV serotypes have failed to do so (Reisinger et al., 2011).
Many other attempts have achieved the in vivo delivery of viruses in the mouse
cochlea, mostly through cochleostomy and round window membrane (reviewed in
Maeda et al., 2009).
The application of silencing in vivo was not a straightforward process. Multiple
viral preparations had to be tested first in vitro and then in vivo, since the titer
was a critical factor for the transduction efficiency. With the first viral preparation,
there was almost no transduction in the organ of Corti, but only some scattered
positive supporting cells and rarely IHCs. In those cases the results were not
conclusive. The results of the second viral preparation, were drastically different.
The viruses were able to transduce IHCs and OHCs with a good indication of
otoferlin silencing in IHCs. Unfortunately, the long process of the experimental
design, the in vitro evaluation, and viral preparation, did not permit the extensive
analysis of many injected animals and the proper evaluation of silencing. It is still
questionable whether silencing was successful at all and if yes, then to what extent.
More systematic analysis by immunolabeling and quantification of otoferlin protein
levels is desirable. Cell physiology experiments at organs of Corti of animals injected
with viruses carrying miRNA silencing molecules will additionally contribute to a
more thorough analysis of the synaptic function after silencing. Finally, testing for
hearing function could provide evidence for a potential silencing-evoked deficit.
The use of miRNA-like silencing molecules, delivered by AAV into the mouse de-
veloping otocyst, is a novel approach to knock-down selected IHC genes and abolish
protein translation. The advantage of this approach is that in some cases it could
possibly substitute the need for generation of a transgenic mouse model. While this
is a newly method, in the future, optimization is intended and if successful, it could
be applied for modifying the levels of any desired protein. For example, in the mouse
IHC ribbon synapse, the role of ribbon and most of its structural components is not
yet clear. The silencing of RIBEYE, the most abundant, ribbon-specific protein,
would allow a more thorough investigation of the role of ribbon in the formation
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and function of the synapse.
In parallel, I studied the synaptic transmission of the otoferlin heterozygous
(Otof+/-) apical IHCs, which also show a modest reduction in the expression level
of otoferlin in IHCs (Pangršič et al., 2010). It was further shown that in these
mice the amplitude of wave I was almost the half of the amplitude in the control
littermates. These two facts intrigued me to test whether the IHC ribbon synapse
can operate with 70% remaining otoferlin levels. I found normal Ca2+-dependent
exocytosis, which obviously indicates that the remaining protein levels suffice for
normal synaptic function. The functional differences in three otoferlin mouse mu-
tants, Otof-/- (Roux et al., 2006), pachanga (Pangršič et al., 2010), and Otof+/- (not
yet fully characterized), indicate that otoferlin has rather a “flexible” mode of func-
tion. Variation in the expression levels, directs the synapse to adjust its function.
From this point of view, it remains to be elucidated what is the minimum level of
protein in order for the synapse to be fully functional.
88
Bibliography
Abell, B.M., Pool, M.R., Schlenker, O., Sinning, I., and High, S.: Signal recognition
particle mediates post-translational targeting in eukaryotes. EMBO J 23 (14):
2755–2764, 2004. PMID: 15229647 PMCID: PMC514945.
Abell, B.M., Rabu, C., Leznicki, P., Young, J.C., and High, S.: Post-translational
integration of tail-anchored proteins is facilitated by defined molecular chaperones.
J Cell Sci 120 (10): 1743–1751, 2007.
Achanzar, W.E. and Ward, S.: A nematode gene required for sperm vesicle fusion.
J Cell Sci 110 (9): 1073–1081, 1997.
Ashmore, J.: Cochlear outer hair cell motility. Physiol Rev 88 (1): 173–210, 2008.
Bansal, D., Miyake, K., Vogel, S.S., Groh, S., Chen, C.C., Williamson, R., Mc-
Neil, P.L., and Campbell, K.P.: Defective membrane repair in dysferlin-deficient
muscular dystrophy. Nature 423 (6936): 168–172, 2003. PMID: 12736685.
Bernatchez, P.N., Sharma, A., Kodaman, P., and Sessa, W.C.: Myoferlin is critical
for endocytosis in endothelial cells. Am J Physiol Cell Physiol 297 (3): C484–
C492, 2009.
Beurg, M., Michalski, N., Safieddine, S., Bouleau, Y., Schneggenburger, R., Chap-
man, E.R., Petit, C., and Dulon, D.: Control of exocytosis by synaptotagmins
and otoferlin in auditory hair cells. J. Neurosci 30 (40): 13.281–13.290, 2010.
PMID: 20926654.
Beutner, D. and Moser, T.: The presynaptic function of mouse cochlear inner hair
cells during development of hearing. J Neurosci 21 (13): 4593, 2001.
89
Bibliography
Borgese, N., Gazzoni, I., Barberi, M., Colombo, S., and Pedrazzini, E.: Targeting of
a tail-anchored protein to endoplasmic reticulum and mitochondrial outer mem-
brane by independent but competing pathways. Mol. Biol. Cell 12 (8): 2482–2496,
2001. PMID: 11514630.
Brandt, A., Striessnig, J., and Moser, T.: CaV1. 3 channels are essential for devel-
opment and presynaptic activity of cochlear inner hair cells. J Neurosci 23 (34):
10.832–10.840, 2003.
Caplen, N.J., Parrish, S., Imani, F., Fire, A., and Morgan, R.A.: Specific inhibition
of gene expression by small double-stranded RNAs in invertebrate and vertebrate
systems. Proc Natl Acad Sci U S A 98 (17): 9742–9747, 2001. PMID: 11481446
PMCID: PMC55523.
Covian-Nares, J.F., Koushik, S.V., Puhl, H.L., and Vogel, S.S.: Membrane wounding
triggers ATP release and dysferlin-mediated intercellular calcium signaling. J Cell
Sci 123 (11): 1884–1893, 2010.
Dallos, P.: The active cochlea. J. Neurosci. 12 (12): 4575–4585, 1992.
Dallos, P.: Cochlear amplification, outer hair cells and prestin. Curr Opin Neurobiol
18 (4): 370–376, 2008. PMID: 18809494 PMCID: PMC2630119.
Deng, L., Kaeser, P.S., Xu, W., and Sdhof, T.C.: RIM proteins activate vesicle
priming by reversing autoinhibitory homodimerization of munc13 69 (2): 317–
331, 2011.
tom Dieck, S., Altrock, W.D., Kessels, M.M., Qualmann, B., Regus, H., Brauner,
D., Fejtov, A., Bracko, O., Gundelfinger, E.D., and Brandsttter, J.H.: Molecular
dissection of the photoreceptor ribbon synapse: physical interaction of bassoon
and RIBEYE is essential for the assembly of the ribbon complex. J Cell Biol
168 (5): 825–836, 2005. PMID: 15728193.
Doherty, K.R., Cave, A., Davis, D.B., Delmonte, A.J., Posey, A., Earley, J.U.,
Hadhazy, M., and McNally, E.M.: Normal myoblast fusion requires myoferlin.
Development 132 (24): 5565–5575, 2005. PMID: 16280346.
90
Dulon, D., Safieddine, S., Jones, S.M., and Petit, C.: Otoferlin is critical for a
highly sensitive and linear calcium-dependent exocytosis at vestibular hair cell
ribbon synapses 29 (34): 10.474 –10.487, 2009.
Egeo, A., Mazzocco, M., Sotgia, F., Arrigo, P., Oliva, R., Bergonn, S., Nizetic, D.,
Rasore-Quartino, A., and Scartezzini, P.: Identification and characterization of
a new human cDNA from chromosome 21q22.3 encoding a basic nuclear protein.
Hum Genet 102 (3): 289–293, 1998.
Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl,
T.: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mam-
malian cells. Nature 411 (6836): 494–498, 2001.
Favaloro, V., Vilardi, F., Schlecht, R., Mayer, M.P., and Dobberstein, B.:
Asna1/TRC40-mediated membrane insertion of tail-anchored proteins. J Cell
Sci 123 (9): 1522–1530, 2010. PMID: 20375064.
Frank, T., Rutherford, M.A., Strenzke, N., Neef, A., Pangri, T., Khimich, D., Fej-
tova, A., Gundelfinger, E.D., Liberman, M.C., Harke, B., Bryan, K.E., Lee, A.,
and Egner: Bassoon and the synaptic ribbon organize ca+ channels and vesicles
to add release sites and promote refilling. Neuron 68 (4): 724–738, 2010.
Fremeau, R.T., Troyer, M.D., Pahner, I., Nygaard, G.O., Tran, C.H., Reimer, R.J.,
Bellocchio, E.E., Fortin, D., Storm-Mathisen, J., and Edwards, R.H.: The expres-
sion of vesicular glutamate transporters defines two classes of excitatory synapse
31 (2): 247–260, 2001.
Gebhart, M., Juhasz-Vedres, G., Zuccotti, A., Brandt, N., Engel, J., Trockenbacher,
A., Kaur, G., Obermair, G.J., Knipper, M., Koschak, A., and Striessnig, J.:
Modulation of cav1.3 ca2+ channel gating by rab3 interacting molecule 44 (3):
246–259, 2010.
Gerges, N.Z., Backos, D.S., and Esteban, J.A.: Local control of AMPA receptor
trafficking at the postsynaptic terminal by a small GTPase of the rab family. J.
Biol. Chem. 279 (42): 43.870–43.878, 2004.
91
Bibliography
Glowatzki, E. and Fuchs, P.A.: Transmitter release at the hair cell ribbon synapse.
Nat Neurosci 5 (2): 147–154, 2002. PMID: 11802170.
Gross, J.M., Perkins, B.D., Amsterdam, A., Egana, A., Darland, T., Matsui, J.I.,
Sciascia, S., Hopkins, N., and Dowling, J.E.: Identification of zebrafish inser-
tional mutants with defects in visual system development and function. Genetics
170 (1): 245–261, 2005. PMID: 15716491 PMCID: PMC1444939.
Hegde, R.S. and Keenan, R.J.: Tail-anchored membrane protein insertion into the
endoplasmic reticulum 2011.
Heidrych, P., Zimmermann, U., Bre, A., Pusch, C.M., Ruth, P., Pfister, M., Knipper,
M., and Blin, N.: Rab8b GTPase, a protein transport regulator, is an interacting
partner of otoferlin, defective in a human autosomal recessive deafness form. Hum.
Mol. Genet. 17 (23): 3814–3821, 2008.
Heidrych, P., Zimmermann, U., Kuhn, S., Franz, C., Engel, J., Duncker, S.V., Hirt,
B., Pusch, C.M., Ruth, P., Pfister, M., Marcotti, W., Blin, N., and Knipper, M.:
Otoferlin interacts with myosin VI: implications for maintenance of the basolateral
synaptic structure of the inner hair cell. Hum. Mol. Genet. 18 (15): 2779–2790,
2009.
Helfmann, S., Neumann, P., Tittmann, K., Moser, T., Ficner, R., and Reisinger, E.:
The crystal structure of the CA domain of otoferlin reveals an unconventional top
loop region. J. Mol. Biol 406 (3): 479–490, 2011. PMID: 21216247.
Jantti, J., Keranen, S., Toikkanen, J., Kuismanen, E., Ehnholm, C., Soderlund,
H., and Olkkonen, V.M.: Membrane insertion and intracellular transport of yeast
syntaxin sso2p in mammalian cells. J Cell Sci 107 (12): 3623–3633, 1994.
Johnson, C.P. and Chapman, E.R.: Otoferlin is a calcium sensor that directly reg-
ulates SNARE-mediated membrane fusion. J Cell Biol 191 (1): 187–197, 2010.
PMID: 20921140 PMCID: PMC2953437.
Johnson, S.L., Franz, C., Kuhn, S., Furness, D.N., Ruttiger, L., Munkner, S., Ri-
volta, M.N., Seward, E.P., Herschman, H.R., Engel, J., Knipper, M., and Mar-
92
cotti, W.: Synaptotagmin IV determines the linear ca2+ dependence of vesicle
fusion at auditory ribbon synapses. Nat Neurosci 13 (1): 45–52, 2010. PMID:
20010821 PMCID: PMC3390740.
Joseph Sambrook and David W. Russell: Molecular Cloning: A Laboratory Manual
(2nd Edition). Cold Spring Harbor Laboratory Press, New York, third edition
edition, 1989.
Kalbfleisch, T., Cambon, A., and Wattenberg, B.W.: A bioinformatics approach to
identifying tail-anchored proteins in the human genome 8 (12): 16871694, 2007.
Khimich, D., Nouvian, R., Pujol, R., tom Dieck, S., Egner, A., Gundelfinger, E.D.,
and Moser, T.: Hair cell synaptic ribbons are essential for synchronous auditory
signalling. Nature 434 (7035): 889–894, 2005.
Kuroda, R., Ikenoue, T., Honsho, M., Tsujimoto, S., Mitoma, J.y., and Ito, A.:
Charged amino acids at the carboxyl-terminal portions determine the intracellular
locations of two isoforms of cytochromeb 5. J. Biol. Chem. 273 (47): 31.097–
31.102, 1998.
Kutay, U., Ahnert-Hilger, G., Hartmann, E., Wiedenmann, B., and Rapoport, T.A.:
Transport route for synaptobrevin via a novel pathway of insertion into the endo-
plasmic reticulum membrane. EMBO J 14 (2): 217–223, 1995. PMID: 7835332
PMCID: PMC398073.
Kutay, U., Hartmann, E., and Rapoport, T.A.: A class of membrane proteins with
a c-terminal anchor. Trends in Cell Biology 3 (3): 72–75, 1993.
Lek, A., Evesson, F.J., Sutton, R.B., North, K.N., and Cooper, S.T.: Ferlins: Reg-
ulators of vesicle fusion for auditory neurotransmission, receptor trafficking and
membrane repair 13 (2): 185194, 2012.
Lenzi, D., Runyeon, J.W., Crum, J., Ellisman, M.H., and Roberts, W.M.: Synaptic
vesicle populations in saccular hair cells reconstructed by electron tomography. J.
Neurosci. 19 (1): 119–132, 1999.
93
Bibliography
Liberman, M.: Single-neuron labeling in the cat auditory nerve 216 (4551): 1239
–1241, 1982.
Linstedt, A.D., Foguet, M., Renz, M., Seelig, H.P., Glick, B.S., and Hauri, H.P.:
A c-terminally-anchored golgi protein is inserted into the endoplasmic reticulum
and then transported to the golgi apparatus. Proc Natl Acad Sci U S A 92 (11):
5102–5105, 1995. PMID: 7761455 PMCID: PMC41856.
Liu, Y.P. and Berkhout, B.: miRNA cassettes in viral vectors: Problems and so-
lutions. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
1809 (1112): 732–745, 2011.
LoGiudice, L., Sterling, P., and Matthews, G.: Mobility and turnover of vesicles at
the synaptic ribbon 28 (12): 3150, 2008.
Manley, G.A.: Cochlear mechanisms from a phylogenetic viewpoint. PNAS 97 (22):
11.736–11.743, 2000.
Mariappan, M., Li, X., Stefanovic, S., Sharma, A., Mateja, A., Keenan, R.J.,
and Hegde, R.S.: A ribosome-associating factor chaperones tail-anchored mem-
brane proteins. Nature 466 (7310): 1120–1124, 2010. PMID: 20676083 PMCID:
PMC2928861.
Melcher, J.R., Guinan Jr, J.H., Knudson, I.M., and Kiang, N.Y.: Generators of
the brainstem auditory evoked potential in cat II. correlating lesion sites with
waveform changes 93 (1-2): 28–51, 1996.
Merchan-Perez, A. and Liberman, M.C.: Ultrastructural differences among afferent
synapses on cochlear hair cells: correlations with spontaneous discharge rate. J.
Comp. Neurol 371 (2): 208–221, 1996. PMID: 8835727.
Meyer, A.C., Frank, T., Khimich, D., Hoch, G., Riedel, D., Chapochnikov, N.M.,
Yarin, Y.M., Harke, B., Hell, S.W., Egner, A., and Moser, T.: Tuning of synapse
number, structure and function in the cochlea. Nat Neurosci 12 (4): 444–453,
2009.
94
Meyer, A.C. and Moser, T.: Structure and function of cochlear afferent innervation.
Curr Opin Otolaryngol Head Neck Surg 18 (5): 441–446, 2010. PMID: 20802334.
Montgomery, M.K. and Fire, A.: Double-stranded RNA as a mediator in sequence-
specific genetic silencing and co-suppression. Trends in Genetics 14 (7): 255–258,
1998.
Moser, T. and Beutner, D.: Kinetics of exocytosis and endocytosis at the cochlear
inner hair cell afferent synapse of the mouse. Proc Natl Acad Sci U S A 97 (2):
883–888, 2000. PMID: 10639174 PMCID: PMC15425.
Moser, T., Brandt, A., and Lysakowski, A.: Hair cell ribbon synapses. Cell Tissue
Res 326 (2): 347–359, 2006.
Munguba, G.C., Camp, A.S., Risco, M., Tapia, M.L., Bhattacharya, S.K., and Lee,
R.K.: Vesicular glutamate transporter 3 in age-dependent optic neuropathy. Mol
Vis 17: 413–419, 2011. PMID: 21311743 PMCID: PMC3036565.
Murata, K., Degmetich, S., Kinoshita, M., and Shimada, E.: Expression of the
congenital heart disease 5/tryptophan rich basic protein homologue gene during
heart development in medaka fish, oryzias latipes 51 (2): 95107, 2009.
Neef, A., Khimich, D., Pirih, P., Riedel, D., Wolf, F., and Moser, T.: Probing the
mechanism of exocytosis at the hair cell ribbon synapse 27 (47): 12.933–12.944,
2007.
Nouvian, R., Beutner, D., Parsons, T., and Moser, T.: Structure and function of
the hair cell ribbon synapse. J Membrane Biol 209 (2-3): 153–165, 2006.
Nouvian, R., Neef, J., Bulankina, A.V., Reisinger, E., Pangri, T., Frank, T., Sikorra,
S., Brose, N., Binz, T., and Moser, T.: Exocytosis at the hair cell ribbon synapse
apparently operates without neuronal SNARE proteins. Nat Neurosci 14 (4):
411–413, 2011.
Ohara-Imaizumi, M., Ohtsuka, T., Matsushima, S., Akimoto, Y., Nishiwaki, C.,
Nakamichi, Y., Kikuta, T., Nagai, S., Kawakami, H., Watanabe, T., and Naga-
matsu, S.: ELKS, a protein structurally related to the active zone-associated
95
Bibliography
protein CAST, is expressed in pancreatic cells and functions in insulin exocy-
tosis: Interaction of ELKS with exocytotic machinery analyzed by total internal
reflection fluorescence microscopy 16 (7): 3289 –3300, 2005.
Pangri, T., Reisinger, E., and Moser, T.: Otoferlin: a multi-c2 domain protein
essential for hearing. Trends Neurosci. 35 (11): 671–680, 2012. PMID: 22959777.
Parsons, T.D. and Sterling, P.: Synaptic ribbon 37 (3): 379–382, 2003.
Pedrazzini, E., Villa, A., and Borgese, N.: A mutant cytochrome b5 with a length-
ened membrane anchor escapes from the endoplasmic reticulum and reaches the
plasma membrane. Proc Natl Acad Sci U S A 93 (9): 4207–4212, 1996. PMID:
8633042 PMCID: PMC39513.
Peter Dallos, Arthur N. Popper, and Richard R. Fay: The Cochlea, volume 8 of IV.
Springer Verlag, New York, Inc, 1996.
Platzer, J., Engel, J., Schrott-Fischer, A., Stephan, K., Bova, S., Chen, H., Zheng,
H., and Striessnig, J.: Congenital deafness and sinoatrial node dysfunction in
mice lacking class d l-type ca2+ channels. Cell 102 (1): 89–97, 2000. PMID:
10929716.
Rabu, C., Schmid, V., Schwappach, B., and High, S.: Biogenesis of tail-anchored
proteins: the beginning for the end? J. Cell. Sci 122 (20): 3605–3612, 2009.
PMID: 19812306.
Rabu, C., Wipf, P., Brodsky, J.L., and High, S.: A precursor-specific role for
Hsp40/Hsc70 during tail-anchored protein integration at the endoplasmic reticu-
lum. J. Biol. Chem. 283 (41): 27.504–27.513, 2008.
Ramakrishnan, N.A., Drescher, M.J., and Drescher, D.G.: Direct interaction of
otoferlin with syntaxin 1A, SNAP-25, and the l-type voltage-gated calcium chan-
nel cav1.3. J. Biol. Chem 284 (3): 1364–1372, 2009. PMID: 19004828.
Reisinger, E., Bresee, C., Neef, J., Nair, R., Reuter, K., Bulankina, A., Nouvian, R.,
Koch, M., Bckers, J., Kastrup, L., Roux, I., Petit, C., Hell, S.W., Brose, N., Rhee,
J.S., Kgler, S., Brigande, J.V., and Moser, T.: Probing the functional equivalence
96
of otoferlin and synaptotagmin 1 in exocytosis. J. Neurosci. 31 (13): 4886–4895,
2011. PMID: 21451027.
Reuter, K.: Biochemistry and physiological role of otoferlin. PhD thesis, University
of Gttingen, 2011.
Rodrguez-Ballesteros, M., Reynoso, R., Olarte, M., Villamar, M., Morera, C.,
Santarelli, R., Arslan, E., Med, C., Curet, C., Vlter, C., Sainz-Quevedo, M., Cas-
torina, P., Ambrosetti, U., Berrettini, S., Frei, K., Tedn, S., Smith, J., Cruz Tapia,
M., Cavall, L., Gelvez, N., Primignani, P., Gmez-Rosas, E., Martn, M., Moreno-
Pelayo, M.A., Tamayo, M., Moreno-Barral, J., Moreno, F., and del Castillo, I.: A
multicenter study on the prevalence and spectrum of mutations in the otoferlin
gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory
neuropathy. Hum. Mutat. 29 (6): 823–831, 2008. PMID: 18381613.
Roux, I., Safieddine, S., Nouvian, R., Grati, M., Simmler, M.C., Bahloul, A., Per-
fettini, I., Le Gall, M., Rostaing, P., Hamard, G., Triller, A., Avan, P., Moser,
T., and Petit, C.: Otoferlin, defective in a human deafness form, is essential for
exocytosis at the auditory ribbon synapse. Cell 127 (2): 277–289, 2006. PMID:
17055430.
Ruel, J., Emery, S., Nouvian, R., Bersot, T., Amilhon, B., Van Rybroek, J.M.,
Rebillard, G., Lenoir, M., Eybalin, M., Delprat, B., Sivakumaran, T.A., Giros,
B., El Mestikawy, S., Moser, T., Smith, R.J., Lesperance, M.M., and Puel, J.L.:
Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3,
underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null
mice. Am J Hum Genet 83 (2): 278–292, 2008. PMID: 18674745 PMCID:
PMC2495073.
Rutherford, M.A., Chapochnikov, N.M., and Moser, T.: Spike encoding of neuro-
transmitter release timing by spiral ganglion neurons of the cochlea. J. Neurosci.
32 (14): 4773–4789, 2012. PMID: 22492033.
Safieddine, S. and Wenthold, R.J.: SNARE complex at the ribbon synapses of
97
Bibliography
cochlear hair cells: analysis of synaptic vesicle- and synaptic membrane-associated
proteins 11 (3): 803812, 1999.
Sakmann, B. and Neher, E.: Patch clamp techniques for studying ionic channels in
excitable membranes. Annu. Rev. Physiol 46: 455–472, 1984. PMID: 6143532.
Schmitz, F., Knigstorfer, A., and Sdhof, T.C.: RIBEYE, a component of synaptic
ribbons 28 (3): 857–872, 2000.
Schug, N., Braig, C., Zimmermann, U., Engel, J., Winter, H., Ruth, P., Blin, N.,
Pfister, M., Kalbacher, H., and Knipper, M.: Differential expression of otoferlin
in brain, vestibular system, immature and mature cochlea of the rat 24 (12):
33723380, 2006.
Schuldiner, M., Metz, J., Schmid, V., Denic, V., Rakwalska, M., Schmitt, H.D.,
Schwappach, B., and Weissman, J.S.: The GET complex mediates insertion of
tail-anchored proteins into the ER membrane. Cell 134 (4): 634–645, 2008.
PMID: 18724936.
Schwander, M., Sczaniecka, A., Grillet, N., Bailey, J.S., Avenarius, M., Najmabadi,
H., Steffy, B.M., Federe, G.C., Lagler, E.A., Banan, R., Hice, R., Grabowski-
Boase, L., Keithley, E.M., Ryan, A.F., Housley, G.D., Wiltshire, T., Smith,
R.J.H., Tarantino, L.M., and Mller, U.: A forward genetics screen in mice iden-
tifies recessive deafness traits and reveals that pejvakin is essential for outer hair
cell function. J. Neurosci. 27 (9): 2163–2175, 2007.
Seal, R.P., Akil, O., Yi, E., Weber, C.M., Grant, L., Yoo, J., Clause, A., Kandler,
K., Noebels, J.L., Glowatzki, E., Lustig, L.R., and Edwards, R.H.: Sensorineural
deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron
57 (2): 263–275, 2008. PMID: 18215623 PMCID: PMC2293283.
Snellman, J., Mehta, B., Babai, N., Bartoletti, T.M., Akmentin, W., Francis, A.,
Matthews, G., Thoreson, W., and Zenisek, D.: Acute destruction of the synaptic
ribbon reveals a role for the ribbon in vesicle priming. Nat Neurosci 14 (9):
1135–1141, 2011. PMID: 21785435.
98
Sobkowicz, H.M. and Slapnick, S.M.: The efferents interconnecting auditory inner
hair cells. Hear. Res. 75 (1-2): 81–92, 1994. PMID: 8071157.
Stefanovic, S. and Hegde, R.S.: Identification of a targeting factor for posttransla-
tional membrane protein insertion into the ER 128 (6): 1147–1159, 2007.
Stefer, S., Reitz, S., Wang, F., Wild, K., Pang, Y.Y., Schwarz, D., Bomke, J., Hein,
C., Lohr, F., Bernhard, F., Denic, V., Dotsch, V., and Sinning, I.: Structural
basis for tail-anchored membrane protein biogenesis by the get3-receptor complex.
Science 333 (6043): 758–762, 2011. PMID: 21719644 PMCID: PMC3601824.
Strenzke, N., Chanda, S., Kopp-Scheinpflug, C., Khimich, D., Reim, K., Bulank-
ina, A.V., Neef, A., Wolf, F., Brose, N., Xu-Friedman, M.A., and Moser, T.:
Complexin-i is required for high-fidelity transmission at the endbulb of held au-
ditory synapse. J. Neurosci. 29 (25): 7991–8004, 2009.
Uthaiah, R.C. and Hudspeth, A.J.: Molecular anatomy of the hair cell’s ribbon
synapse. J. Neurosci. 30 (37): 12.387–12.399, 2010.
Vilardi, F., Lorenz, H., and Dobberstein, B.: WRB is the receptor for
TRC40/Asna1-mediated insertion of tail-anchored proteins into the ER mem-
brane. J. Cell. Sci. 124 (8): 1301–1307, 2011. PMID: 21444755.
Wang, F., Whynot, A., Tung, M., and Denic, V.: The mechanism of tail-anchored
protein insertion into the ER membrane 43 (5): 738–750, 2011.
Wattenberg, B. and Lithgow, T.: Targeting of c-terminal (tail)-anchored proteins:
Understanding how cytoplasmic activities are anchored to intracellular mem-
branes 2 (1): 6671, 2001.
Winter, J., Jung, S., Keller, S., Gregory, R.I., and Diederichs, S.: Many roads to
maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol
11 (3): 228–234, 2009.
Yamamoto, Y. and Sakisaka, T.: Molecular machinery for insertion of tail-anchored
membrane proteins into the endoplasmic reticulum membrane in mammalian cells.
Molecular Cell 48 (3): 387–397, 2012.
99
Yasunaga, S., Grati, M., Cohen-Salmon, M., El-Amraoui, A., Mustapha, M., Salem,
N., El-Zir, E., Loiselet, J., and Petit, C.: A mutation in OTOF, encoding otoferlin,
a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet
21 (4): 363–369, 1999.
Zhai, R.G. and Bellen, H.J.: The architecture of the active zone in the presynaptic
nerve terminal. Physiology 19 (5): 262–270, 2004.
Zheng, J., Shen, W., He, D.Z., Long, K.B., Madison, L.D., and Dallos, P.: Prestin
is the motor protein of cochlear outer hair cells 405 (6783): 149155, 2000.
100
Iliana Panou
Birth: September 15th, 1984, Athens, Greece.
Innear Ear Lab
Robert-Koch Strasse 40 E-mail: ilianapanou@gmail.com





Georg-August University of Goettingen, Germany
Thesis title: “The role of tryptophan-rich basic protein (WRB) in inner hair cell
synaptic transmission and hearing.”
Diploma, Biology, grade 7.66/10 2007
Aristotle University of Thessaloniki, Thessaloniki, Greece
Specialization in Molecular Biology, Genetics, and Biotechnology
High School Degree, Lyceum, grade 18.1/20 2002
Geitonas Private High School, Athens, Greece
Innear Ear Lab, Medical School, Goettingen, Germany Apr 09 - Mar 13Research
Experience Ph.D. student
Advisors: Prof. Dr. Med. Tobias Moser, Dr. Tina Pangršič
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